| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.912 | 0.001 | 0.912 | 5 Hydroxytryptamine release stimulant | 0.896 0.002 DBMET00316 0.745 0.005 DBMET03178 0.689 0.008 DBMET03179 0.815 0.003 DBMET03180 0.686 0.008 DBMET03181 | ||
| 0.728 | 0.009 | 0.728 | Antiobesity | 0.512 0.035 DBMET00316 0.241 0.166 DBMET03178 0.352 0.086 DBMET03180 0.671 0.013 DBMET03181 | ||
| 0.579 | 0.003 | 0.617 | 5 Hydroxytryptamine uptake stimulant | 0.617 0.003 DBMET00316 0.332 0.031 DBMET03178 0.335 0.03 DBMET03179 0.3 0.045 DBMET03180 0.208 0.136 DBMET03181 | DBMET00316 | |
| 0.565 | 0.007 | 0.565 | Psychostimulant | 0.494 0.011 DBMET00316 0.204 0.078 DBMET03179 0.148 0.118 DBMET03180 0.152 0.115 DBMET03181 | ||
| 0.494 | 0.016 | 0.494 | Cardiotonic | 0.276 0.067 DBMET03180 0.176 0.144 DBMET03181 | ||
| 0.456 | 0.022 | 0.456 | Vasodilator, coronary | 0.281 0.104 DBMET00316 0.351 0.054 DBMET03180 0.314 0.077 DBMET03181 | ||
| 0.467 | 0.059 | 0.572 | Analgesic | 0.572 0.032 DBMET00316 0.456 0.063 DBMET03178 0.355 0.106 DBMET03180 0.349 0.109 DBMET03181 | DBMET00316 | |
| 0.445 | 0.041 | 0.663 | Cholesterol antagonist | 0.362 0.059 DBMET00316 0.396 0.05 DBMET03178 0.206 0.16 DBMET03179 0.663 0.011 DBMET03180 0.61 0.017 DBMET03181 | DBMET03180 | |
| 0.46 | 0.063 | 0.762 | Cyclophilin D inhibitor | 0.357 0.117 DBMET00316 0.258 0.204 DBMET03178 0.762 0.009 DBMET03180 0.669 0.018 DBMET03181 | DBMET03180 | |
| 0.424 | 0.064 | 0.55 | 5 Hydroxytryptamine release inhibitor | 0.537 0.022 DBMET00316 0.424 0.064 DBMET03178 0.341 0.123 DBMET03179 0.55 0.019 DBMET03180 0.534 0.023 DBMET03181 | DBMET03180 | |
| 0.331 | 0.007 | 0.331 | Nav1.3 sodium channel blocker | 0.143 0.053 DBMET00316 0.177 0.033 DBMET03180 0.168 0.038 DBMET03181 | ||
| 0.368 | 0.047 | 0.368 | Spasmolytic | 0.226 0.102 DBMET00316 0.197 0.122 DBMET03180 0.349 0.053 DBMET03181 | ||
| 0.337 | 0.019 | 0.409 | Tyrosine 3 hydroxylase inhibitor | 0.409 0.007 DBMET00316 0.285 0.041 DBMET03178 0.313 0.028 DBMET03179 0.263 0.057 DBMET03180 0.194 0.146 DBMET03181 | DBMET00316 | |
| 0.408 | 0.094 | 0.484 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.451 0.06 DBMET00316 0.484 0.042 DBMET03178 0.319 0.188 DBMET03179 0.436 0.071 DBMET03180 0.418 0.086 DBMET03181 | DBMET03178 | |
| 0.381 | 0.071 | 0.381 | Calpain 2 inhibitor | 0.264 0.139 DBMET00316 0.291 0.12 DBMET03178 | ||
| 0.289 | 0.016 | 0.289 | Nav1.2 sodium channel blocker | 0.229 0.026 DBMET00316 0.114 0.09 DBMET03178 0.204 0.033 DBMET03180 0.151 0.056 DBMET03181 | ||
| 0.372 | 0.101 | 0.579 | Calcium channel L-type activator | 0.404 0.079 DBMET00316 0.443 0.055 DBMET03178 0.257 0.197 DBMET03179 0.45 0.05 DBMET03180 0.579 0.008 DBMET03181 | DBMET03181 | |
| 0.309 | 0.047 | 0.46 | Superoxide dismutase inhibitor | 0.46 0.017 DBMET00316 0.328 0.042 DBMET03178 0.175 0.148 DBMET03179 0.305 0.049 DBMET03180 0.234 0.086 DBMET03181 | DBMET00316 | |
| 0.313 | 0.051 | 0.377 | Insulysin inhibitor | 0.354 0.033 DBMET00316 0.294 0.062 DBMET03178 0.377 0.026 DBMET03179 0.25 0.096 DBMET03180 | DBMET03179 | |
| 0.286 | 0.026 | 0.286 | Neuropeptide Y2 antagonist | 0.283 0.028 DBMET00316 0.235 0.071 DBMET03178 0.18 0.16 DBMET03179 0.26 0.047 DBMET03180 0.253 0.054 DBMET03181 | ||
| 0.263 | 0.007 | 0.263 | Calcium channel N-type blocker | 0.191 0.019 DBMET00316 0.123 0.059 DBMET03178 0.116 0.068 DBMET03180 | ||
| 0.292 | 0.038 | 0.292 | Gastrin inhibitor | 0.204 0.143 DBMET00316 0.198 0.152 DBMET03180 | ||
| 0.284 | 0.038 | 0.284 | Calpain inhibitor | 0.258 0.057 DBMET00316 0.22 0.095 DBMET03178 0.175 0.141 DBMET03179 | ||
| 0.374 | 0.128 | 0.601 | Caspase 9 stimulant | 0.402 0.11 DBMET00316 0.601 0.036 DBMET03178 0.458 0.079 DBMET03179 0.499 0.06 DBMET03180 0.466 0.075 DBMET03181 | DBMET03178 | |
| 0.253 | 0.016 | 0.253 | Calcium channel blocker | 0.149 0.059 DBMET00316 0.123 0.084 DBMET03178 0.14 0.068 DBMET03180 | ||
| 0.246 | 0.01 | 0.246 | Nav1.6 sodium channel blocker | 0.195 0.021 DBMET00316 0.146 0.058 DBMET03178 0.18 0.028 DBMET03180 0.167 0.037 DBMET03181 | ||
| 0.244 | 0.013 | 0.244 | Bronchodilator | 0.234 0.014 DBMET03181 | ||
| 0.279 | 0.059 | 0.315 | Antiamyloidogenic | 0.315 0.047 DBMET00316 0.155 0.14 DBMET03180 | DBMET00316 | |
| 0.239 | 0.022 | 0.239 | 5 Hydroxytryptamine 3E antagonist | 0.215 0.042 DBMET00316 0.19 0.081 DBMET03178 | ||
| 0.223 | 0.013 | 0.223 | Calcium channel (voltage-sensitive) blocker | 0.136 0.042 DBMET00316 0.116 0.062 DBMET03178 0.111 0.068 DBMET03180 | ||
| 0.232 | 0.024 | 0.232 | Anesthetic local | 0.107 0.077 DBMET00316 0.104 0.079 DBMET03180 0.15 0.049 DBMET03181 | ||
| 0.213 | 0.014 | 0.213 | Ca(v)2.2 blocker | 0.192 0.018 DBMET00316 0.119 0.039 DBMET03178 0.075 0.07 DBMET03179 0.145 0.031 DBMET03180 | ||
| 0.237 | 0.042 | 0.38 | Insulin sensitizer | 0.266 0.026 DBMET00316 0.197 0.076 DBMET03178 0.166 0.113 DBMET03179 0.38 0.007 DBMET03180 0.316 0.013 DBMET03181 | DBMET03180 | |
| 0.206 | 0.013 | 0.206 | Calcium antagonist | 0.082 0.062 DBMET00316 0.116 0.037 DBMET03178 0.126 0.032 DBMET03180 0.129 0.031 DBMET03181 | ||
| 0.217 | 0.034 | 0.218 | Thiol protease inhibitor | 0.218 0.034 DBMET00316 0.181 0.048 DBMET03178 0.123 0.111 DBMET03180 | DBMET00316 | |
| 0.204 | 0.025 | 0.258 | Adenylate cyclase inhibitor | 0.189 0.028 DBMET00316 0.125 0.063 DBMET03178 0.232 0.021 DBMET03179 0.258 0.018 DBMET03180 0.218 0.023 DBMET03181 | DBMET03180 | |
| 0.247 | 0.068 | 0.581 | Hypolipemic | 0.151 0.135 DBMET00316 0.373 0.03 DBMET03178 0.581 0.007 DBMET03180 0.513 0.011 DBMET03181 | DBMET03180 | |
| 0.201 | 0.024 | 0.201 | Antiadrenergic | 0.113 0.048 DBMET03181 | ||
| 0.194 | 0.025 | 0.194 | Adrenaline antagonist | 0.111 0.048 DBMET03181 | ||
| 0.175 | 0.01 | 0.175 | Adrenaline agonist | 0.101 0.036 DBMET00316 0.107 0.032 DBMET03180 0.136 0.019 DBMET03181 | ||
| 0.187 | 0.022 | 0.187 | Nav1.1 sodium channel blocker | 0.104 0.061 DBMET00316 0.187 0.022 DBMET03180 0.145 0.035 DBMET03181 | ||
| 0.24 | 0.075 | 0.24 | Vasodilator | 0.156 0.149 DBMET03178 | ||
| 0.284 | 0.121 | 0.371 | Toll-Like receptor 7 agonist | 0.371 0.072 DBMET03181 | DBMET03181 | |
| 0.178 | 0.015 | 0.217 | Sphingomyelinase inhibitor | 0.122 0.04 DBMET00316 0.108 0.051 DBMET03178 0.217 0.007 DBMET03179 0.161 0.02 DBMET03180 0.185 0.013 DBMET03181 | DBMET03179 | |
| 0.281 | 0.123 | 0.37 | Toll-Like receptor agonist | 0.37 0.073 DBMET03181 | DBMET03181 | |
| 0.269 | 0.114 | 0.378 | Transcription factor NF kappa B inhibitor | 0.378 0.069 DBMET00316 0.312 0.089 DBMET03178 0.323 0.085 DBMET03180 0.275 0.11 DBMET03181 | DBMET00316 | |
| 0.223 | 0.068 | 0.282 | Anticonvulsant | 0.195 0.086 DBMET00316 0.282 0.045 DBMET03178 0.148 0.131 DBMET03180 0.171 0.106 DBMET03181 | DBMET03178 | |
| 0.198 | 0.05 | 0.221 | Antipruritic | 0.221 0.036 DBMET00316 0.159 0.085 DBMET03180 0.148 0.097 DBMET03181 | DBMET00316 | |
| 0.168 | 0.022 | 0.188 | Sphingosine 1-phosphate receptor 2 antagonist | 0.188 0.011 DBMET00316 0.173 0.019 DBMET03178 0.123 0.088 DBMET03179 0.178 0.016 DBMET03180 0.155 0.034 DBMET03181 | DBMET00316 | |
| 0.248 | 0.104 | 0.254 | Ca(v)3.3 blocker | 0.246 0.107 DBMET00316 0.254 0.095 DBMET03178 | DBMET03178 | |
| 0.269 | 0.125 | 0.424 | Calcium channel activator | 0.302 0.09 DBMET00316 0.349 0.051 DBMET03178 0.213 0.194 DBMET03179 0.374 0.036 DBMET03180 0.424 0.017 DBMET03181 | DBMET03181 | |
| 0.183 | 0.047 | 0.193 | Neurotensin receptor agonist | 0.193 0.039 DBMET00316 | DBMET00316 | |
| 0.17 | 0.035 | 0.172 | Adenylate cyclase stimulant | 0.163 0.044 DBMET00316 0.136 0.09 DBMET03178 0.146 0.069 DBMET03179 0.158 0.05 DBMET03180 0.172 0.033 DBMET03181 | DBMET03181 | |
| 0.136 | 0.006 | 0.167 | Neurokinin antagonist | 0.167 0.005 DBMET00316 0.125 0.007 DBMET03178 0.059 0.026 DBMET03179 0.095 0.013 DBMET03180 0.134 0.006 DBMET03181 | DBMET00316 | |
| 0.149 | 0.023 | 0.195 | Nitric-oxide synthase inhibitor | 0.195 0.01 DBMET00316 0.112 0.044 DBMET03178 0.094 0.071 DBMET03180 | DBMET00316 | |
| 0.131 | 0.006 | 0.237 | 5 Hydroxytryptamine 2 agonist | 0.237 0.004 DBMET00316 | DBMET00316 | |
| 0.164 | 0.039 | 0.164 | Proteasome inhibitor | 0.148 0.047 DBMET00316 0.126 0.061 DBMET03178 0.118 0.067 DBMET03180 | ||
| 0.129 | 0.005 | 0.163 | Neurokinin 1 antagonist | 0.163 0.005 DBMET00316 0.131 0.005 DBMET03178 0.066 0.013 DBMET03179 0.096 0.007 DBMET03180 0.152 0.005 DBMET03181 | DBMET00316 | |
| 0.2 | 0.077 | 0.391 | Neurotrophic factor enhancer | 0.286 0.022 DBMET00316 0.391 0.006 DBMET03178 0.179 0.1 DBMET03179 0.366 0.008 DBMET03180 0.304 0.017 DBMET03181 | DBMET03178 | |
| 0.136 | 0.014 | 0.163 | Glutamate release inhibitor | 0.13 0.016 DBMET00316 0.131 0.016 DBMET03178 0.149 0.01 DBMET03180 0.163 0.007 DBMET03181 | DBMET03181 | |
| 0.127 | 0.005 | 0.159 | Substance P antagonist | 0.159 0.005 DBMET00316 0.089 0.006 DBMET03178 0.049 0.017 DBMET03179 0.064 0.01 DBMET03180 0.1 0.005 DBMET03181 | DBMET00316 | |
| 0.182 | 0.061 | 0.188 | Thrombolytic | 0.188 0.058 DBMET00316 0.166 0.07 DBMET03180 | DBMET00316 | |
| 0.127 | 0.008 | 0.315 | 5 Hydroxytryptamine 2A agonist | 0.315 0.003 DBMET00316 0.058 0.049 DBMET03178 | DBMET00316 | |
| 0.131 | 0.013 | 0.131 | Calcium channel L-type blocker | 0.086 0.034 DBMET00316 0.096 0.027 DBMET03178 0.096 0.027 DBMET03180 0.068 0.055 DBMET03181 | ||
| 0.12 | 0.005 | 0.12 | Sigma 1 receptor antagonist | |||
| 0.128 | 0.014 | 0.161 | Sphingosine 1-phosphate receptor 4 agonist | 0.161 0.007 DBMET00316 0.112 0.019 DBMET03178 0.156 0.008 DBMET03180 0.142 0.01 DBMET03181 | DBMET00316 | |
| 0.15 | 0.038 | 0.231 | Aminopeptidase B inhibitor | 0.215 0.018 DBMET00316 0.129 0.048 DBMET03178 0.231 0.015 DBMET03179 0.158 0.034 DBMET03180 0.096 0.068 DBMET03181 | DBMET03179 | |
| 0.144 | 0.033 | 0.167 | GABA C receptor antagonist | 0.146 0.032 DBMET00316 0.125 0.048 DBMET03178 0.167 0.022 DBMET03179 0.161 0.025 DBMET03180 0.128 0.045 DBMET03181 | DBMET03179 | |
| 0.16 | 0.05 | 0.392 | Alpha-N-acetylglucosaminidase inhibitor | 0.18 0.041 DBMET00316 0.186 0.038 DBMET03178 0.134 0.065 DBMET03179 0.392 0.009 DBMET03180 0.366 0.011 DBMET03181 | DBMET03180 | |
| 0.119 | 0.01 | 0.119 | Beta 3 adrenoreceptor antagonist | 0.078 0.025 DBMET03180 0.098 0.015 DBMET03181 | ||
| 0.231 | 0.124 | 0.231 | Nootropic | 0.197 0.163 DBMET03181 | ||
| 0.151 | 0.046 | 0.199 | Cathepsin H inhibitor | 0.199 0.023 DBMET00316 0.134 0.06 DBMET03178 0.18 0.029 DBMET03180 | DBMET00316 | |
| 0.197 | 0.094 | 0.323 | Nitric-oxide synthase stimulant | 0.226 0.053 DBMET00316 0.212 0.071 DBMET03178 0.269 0.022 DBMET03180 0.323 0.007 DBMET03181 | DBMET03181 | |
| 0.137 | 0.036 | 0.139 | Nav1.5 sodium channel blocker | 0.139 0.035 DBMET00316 0.111 0.066 DBMET03178 0.137 0.036 DBMET03180 0.119 0.056 DBMET03181 | DBMET00316 | |
| 0.158 | 0.057 | 0.225 | Cytokine production inhibitor | 0.184 0.042 DBMET00316 0.225 0.029 DBMET03178 0.108 0.102 DBMET03179 0.139 0.071 DBMET03180 | DBMET03178 | |
| 0.17 | 0.071 | 0.265 | ATPase inhibitor | 0.166 0.076 DBMET00316 0.175 0.065 DBMET03178 0.162 0.083 DBMET03179 0.265 0.01 DBMET03180 0.204 0.034 DBMET03181 | DBMET03180 | |
| 0.098 | 0.002 | 0.098 | Histamine H1 receptor agonist | 0.086 0.003 DBMET00316 0.053 0.015 DBMET03178 0.041 0.038 DBMET03179 | ||
| 0.109 | 0.014 | 0.122 | Secretase beta inhibitor | 0.121 0.01 DBMET00316 0.065 0.059 DBMET03178 0.122 0.01 DBMET03180 0.093 0.023 DBMET03181 | DBMET03180 | |
| 0.115 | 0.021 | 0.166 | Aminopeptidase I inhibitor | 0.166 0.01 DBMET00316 0.096 0.03 DBMET03178 0.085 0.038 DBMET03179 0.13 0.017 DBMET03180 0.089 0.035 DBMET03181 | DBMET00316 | |
| 0.105 | 0.015 | 0.105 | Beta adrenoreceptor antagonist | 0.083 0.025 DBMET03180 0.098 0.017 DBMET03181 | ||
| 0.149 | 0.063 | 0.205 | Sphingosine 1-phosphate receptor 5 antagonist | 0.205 0.009 DBMET00316 0.191 0.016 DBMET03178 0.194 0.014 DBMET03180 0.147 0.067 DBMET03181 | DBMET00316 | |
| 0.105 | 0.019 | 0.116 | Estrogen-related receptor beta agonist | 0.093 0.035 DBMET00316 0.116 0.012 DBMET03178 0.079 0.072 DBMET03179 0.11 0.015 DBMET03180 0.087 0.046 DBMET03181 | DBMET03178 | |
| 0.113 | 0.028 | 0.163 | Inducible nitric-oxide synthase inhibitor | 0.163 0.013 DBMET00316 0.127 0.022 DBMET03178 0.094 0.042 DBMET03180 0.078 0.065 DBMET03181 | DBMET00316 | |
| 0.133 | 0.049 | 0.162 | 5 Hydroxytryptamine 2B antagonist | 0.162 0.036 DBMET00316 | DBMET00316 | |
| 0.229 | 0.145 | 0.43 | Vasodilator, peripheral | 0.194 0.184 DBMET00316 0.237 0.137 DBMET03178 0.295 0.1 DBMET03180 0.43 0.046 DBMET03181 | DBMET03181 | |
| 0.092 | 0.009 | 0.092 | Epithelial sodium channel blocker | 0.088 0.01 DBMET00316 0.059 0.03 DBMET03178 0.066 0.021 DBMET03180 0.052 0.045 DBMET03181 | ||
| 0.173 | 0.092 | 0.301 | Anesthetic general | 0.24 0.055 DBMET00316 0.301 0.033 DBMET03178 0.283 0.038 DBMET03180 0.257 0.047 DBMET03181 | DBMET03178 | |
| 0.125 | 0.044 | 0.13 | Protease inhibitor | 0.125 0.044 DBMET00316 0.094 0.07 DBMET03179 0.13 0.041 DBMET03180 0.086 0.079 DBMET03181 | DBMET03180 | |
| 0.143 | 0.063 | 0.202 | Sodium channel blocker | 0.166 0.047 DBMET00316 0.122 0.082 DBMET03180 0.202 0.032 DBMET03181 | DBMET03181 | |
| 0.086 | 0.006 | 0.086 | Beta 2 adrenoreceptor agonist | 0.071 0.018 DBMET00316 0.067 0.027 DBMET03180 0.071 0.018 DBMET03181 | ||
| 0.115 | 0.035 | 0.154 | ABCA1 expression enhancer | 0.085 0.076 DBMET00316 0.119 0.031 DBMET03178 0.154 0.016 DBMET03180 0.101 0.049 DBMET03181 | DBMET03180 | |
| 0.135 | 0.057 | 0.164 | Vanilloid 1 agonist | 0.162 0.028 DBMET00316 0.154 0.035 DBMET03178 0.116 0.096 DBMET03179 0.164 0.027 DBMET03180 0.114 0.103 DBMET03181 | DBMET03180 | |
| 0.119 | 0.041 | 0.151 | Creatine kinase inhibitor | 0.151 0.024 DBMET00316 0.136 0.03 DBMET03178 0.138 0.029 DBMET03180 0.119 0.041 DBMET03181 | DBMET00316 | |
| 0.142 | 0.066 | 0.181 | Ca2+-transporting ATPase inhibitor | 0.159 0.025 DBMET00316 0.172 0.012 DBMET03178 0.145 0.056 DBMET03179 0.178 0.008 DBMET03180 0.181 0.007 DBMET03181 | DBMET03181 | |
| 0.091 | 0.015 | 0.091 | Potassium channel (Tandem pore domain) blocker | 0.086 0.022 DBMET00316 0.087 0.021 DBMET03178 0.087 0.021 DBMET03180 0.084 0.026 DBMET03181 | ||
| 0.131 | 0.057 | 0.131 | Acetylcholine muscarinic antagonist | 0.106 0.084 DBMET03181 | ||
| 0.09 | 0.015 | 0.09 | Bombesin 2 receptor antagonist | 0.074 0.018 DBMET00316 0.053 0.03 DBMET03179 0.053 0.03 DBMET03180 | ||
| 0.146 | 0.072 | 0.146 | Neuropeptide Y1 antagonist | 0.137 0.086 DBMET00316 | ||
| 0.116 | 0.043 | 0.12 | Factor V inhibitor | 0.12 0.039 DBMET00316 | DBMET00316 | |
| 0.086 | 0.014 | 0.086 | Beta 1 adrenoreceptor antagonist | 0.078 0.019 DBMET03180 0.083 0.016 DBMET03181 | ||
| 0.108 | 0.036 | 0.121 | Ornithine decarboxylase inhibitor | 0.121 0.025 DBMET00316 0.1 0.044 DBMET03178 0.105 0.039 DBMET03180 0.105 0.039 DBMET03181 | DBMET00316 | |
| 0.084 | 0.013 | 0.111 | Neurokinin 2 antagonist | 0.111 0.009 DBMET00316 0.04 0.03 DBMET03178 0.039 0.032 DBMET03180 | DBMET00316 | |
| 0.102 | 0.032 | 0.102 | Myeloperoxidase inhibitor | 0.1 0.035 DBMET00316 0.085 0.057 DBMET03178 0.094 0.043 DBMET03179 | ||
| 0.084 | 0.014 | 0.085 | Corticotropin releasing factor 2 receptor antagonist | 0.085 0.013 DBMET00316 0.06 0.047 DBMET03178 0.062 0.042 DBMET03180 | DBMET00316 | |
| 0.09 | 0.02 | 0.108 | Protease 3C (Human rhinovirus) inhibitor | 0.108 0.013 DBMET00316 0.092 0.019 DBMET03178 0.066 0.041 DBMET03180 | DBMET00316 | |
| 0.08 | 0.012 | 0.08 | Beta 2 adrenoreceptor antagonist | 0.067 0.019 DBMET03180 0.073 0.015 DBMET03181 | ||
| 0.08 | 0.014 | 0.08 | Histamine agonist | 0.067 0.021 DBMET00316 | ||
| 0.107 | 0.042 | 0.137 | 5 Hydroxytryptamine 2C antagonist | 0.137 0.03 DBMET00316 | DBMET00316 | |
| 0.082 | 0.017 | 0.182 | Glycine transporter 2 inhibitor | 0.182 0.006 DBMET00316 0.045 0.034 DBMET03180 | DBMET00316 | |
| 0.103 | 0.038 | 0.204 | Catalase inhibitor | 0.194 0.016 DBMET00316 0.204 0.014 DBMET03178 0.193 0.016 DBMET03180 0.201 0.015 DBMET03181 | DBMET03178 | |
| 0.071 | 0.006 | 0.175 | 5 Hydroxytryptamine 2B agonist | 0.175 0.003 DBMET00316 0.039 0.027 DBMET03178 | DBMET00316 | |
| 0.097 | 0.033 | 0.4 | 5 Hydroxytryptamine 1F antagonist | 0.4 0.005 DBMET00316 | DBMET00316 | |
| 0.106 | 0.044 | 0.114 | Opioid antagonist | 0.114 0.039 DBMET00316 | DBMET00316 | |
| 0.087 | 0.025 | 0.087 | Phospholipase D inhibitor | 0.066 0.062 DBMET00316 | ||
| 0.131 | 0.069 | 0.173 | MAO inhibitor | 0.173 0.05 DBMET00316 | DBMET00316 | |
| 0.083 | 0.022 | 0.203 | Exportin-1 inhibitor | 0.119 0.005 DBMET00316 0.155 0.003 DBMET03178 0.068 0.047 DBMET03179 0.172 0.003 DBMET03180 0.203 0.002 DBMET03181 | DBMET03181 | |
| 0.091 | 0.031 | 0.121 | Epoxide hydrolase inhibitor | 0.068 0.056 DBMET00316 0.121 0.017 DBMET03178 0.078 0.044 DBMET03180 | DBMET03178 | |
| 0.071 | 0.012 | 0.112 | Adenylate cyclase 1 inhibitor | 0.075 0.01 DBMET00316 0.1 0.004 DBMET03178 0.096 0.005 DBMET03179 0.112 0.004 DBMET03180 0.087 0.005 DBMET03181 | DBMET03180 | |
| 0.112 | 0.053 | 0.123 | Carbonic anhydrase XV inhibitor | 0.123 0.045 DBMET00316 0.117 0.049 DBMET03178 0.092 0.08 DBMET03180 | DBMET00316 | |
| 0.103 | 0.045 | 0.103 | Potassium channel activator | 0.089 0.062 DBMET00316 0.095 0.054 DBMET03178 0.08 0.075 DBMET03180 | ||
| 0.128 | 0.07 | 0.201 | Toll-Like receptor 2 antagonist | 0.171 0.039 DBMET00316 0.138 0.061 DBMET03178 0.201 0.023 DBMET03180 0.156 0.049 DBMET03181 | DBMET03180 | |
| 0.076 | 0.018 | 0.171 | Sphingosine kinase 2 inhibitor | 0.146 0.004 DBMET00316 0.089 0.011 DBMET03178 0.068 0.023 DBMET03179 0.171 0.003 DBMET03180 0.094 0.009 DBMET03181 | DBMET03180 | |
| 0.076 | 0.018 | 0.076 | Heme oxygenase stimulant | 0.061 0.042 DBMET00316 0.073 0.021 DBMET03178 0.069 0.027 DBMET03180 0.066 0.032 DBMET03181 | ||
| 0.106 | 0.049 | 0.106 | Prolactin inhibitor | 0.106 0.049 DBMET00316 | ||
| 0.095 | 0.038 | 0.205 | CYP2A6 inhibitor | 0.205 0.007 DBMET00316 0.173 0.011 DBMET03178 0.067 0.063 DBMET03179 0.099 0.037 DBMET03180 | DBMET00316 | |
| 0.174 | 0.118 | 0.283 | Cyclic AMP phosphodiesterase inhibitor | 0.283 0.049 DBMET03178 0.193 0.099 DBMET03180 0.19 0.101 DBMET03181 | DBMET03178 | |
| 0.077 | 0.021 | 0.077 | Sigma receptor antagonist | |||
| 0.068 | 0.012 | 0.068 | Gonadotropin-releasing hormone receptor antagonist | |||
| 0.08 | 0.025 | 0.202 | TRPA1 antagonist | 0.079 0.026 DBMET00316 0.202 0.005 DBMET03178 0.054 0.052 DBMET03179 0.117 0.014 DBMET03180 | DBMET03178 | |
| 0.105 | 0.05 | 0.11 | Glutamate (mGluR7) agonist | 0.11 0.043 DBMET00316 | DBMET00316 | |
| 0.075 | 0.021 | 0.124 | Potassium channel intermediate-conductance Ca-activated blocker | 0.093 0.011 DBMET00316 0.095 0.01 DBMET03178 0.124 0.005 DBMET03179 0.066 0.032 DBMET03180 | DBMET03179 | |
| 0.062 | 0.008 | 0.062 | Potassium channel Kv1.1 blocker | 0.06 0.009 DBMET00316 0.054 0.011 DBMET03178 0.036 0.031 DBMET03179 | ||
| 0.112 | 0.059 | 0.112 | Interleukin 2 antagonist | 0.105 0.076 DBMET00316 | ||
| 0.09 | 0.037 | 0.09 | Ca(v)3.1 blocker | 0.088 0.041 DBMET03178 | ||
| 0.067 | 0.016 | 0.095 | Lysophosphatidic acid 3 receptor antagonist | 0.076 0.011 DBMET00316 0.069 0.015 DBMET03178 0.058 0.024 DBMET03179 0.095 0.005 DBMET03180 0.091 0.006 DBMET03181 | DBMET03180 | |
| 0.059 | 0.008 | 0.059 | Beta adrenoreceptor agonist | 0.045 0.031 DBMET00316 0.05 0.018 DBMET03180 0.054 0.012 DBMET03181 | ||
| 0.08 | 0.029 | 0.092 | NMDA receptor agonist | 0.092 0.022 DBMET00316 0.056 0.053 DBMET03179 | DBMET00316 | |
| 0.089 | 0.039 | 0.092 | CC chemokine 5 receptor agonist | 0.086 0.046 DBMET00316 0.092 0.033 DBMET03178 0.085 0.048 DBMET03180 | DBMET03178 | |
| 0.136 | 0.086 | 0.168 | Hemostatic | 0.168 0.05 DBMET00316 0.119 0.117 DBMET03180 | DBMET00316 | |
| 0.072 | 0.023 | 0.093 | Sphingosine 1-phosphate receptor 3 antagonist | 0.093 0.01 DBMET00316 0.088 0.012 DBMET03178 0.088 0.012 DBMET03180 0.082 0.015 DBMET03181 | DBMET00316 | |
| 0.083 | 0.035 | 0.34 | Phenylalanine 4-hydroxylase inhibitor | 0.167 0.009 DBMET00316 0.065 0.051 DBMET03178 0.188 0.008 DBMET03179 0.189 0.008 DBMET03180 0.34 0.004 DBMET03181 | DBMET03181 | |
| 0.071 | 0.022 | 0.071 | Protease activated receptor 1 antagonist | 0.057 0.029 DBMET00316 | ||
| 0.089 | 0.041 | 0.089 | Vanilloid antagonist | 0.066 0.06 DBMET03178 0.067 0.06 DBMET03180 | ||
| 0.073 | 0.028 | 0.075 | Cathepsin L inhibitor | 0.075 0.027 DBMET00316 0.063 0.035 DBMET03178 | DBMET00316 | |
| 0.066 | 0.02 | 0.085 | Dipeptidyl peptidase inhibitor | 0.085 0.012 DBMET00316 | DBMET00316 | |
| 0.062 | 0.018 | 0.062 | Potassium channel (Inward rectifier) activator | 0.059 0.021 DBMET00316 0.055 0.027 DBMET03178 0.048 0.041 DBMET03180 | ||
| 0.134 | 0.091 | 0.134 | Acetylcholine M1 receptor antagonist | 0.126 0.101 DBMET00316 | ||
| 0.068 | 0.026 | 0.068 | CC chemokine 2 receptor antagonist | 0.058 0.034 DBMET00316 0.068 0.026 DBMET03180 0.061 0.031 DBMET03181 | ||
| 0.059 | 0.017 | 0.059 | Potassium channel (ATP-sensitive) activator | 0.056 0.02 DBMET00316 0.052 0.026 DBMET03178 0.046 0.039 DBMET03180 | ||
| 0.061 | 0.019 | 0.065 | Neurokinin 3 antagonist | 0.065 0.016 DBMET00316 0.063 0.017 DBMET03178 0.041 0.035 DBMET03180 0.041 0.035 DBMET03181 | DBMET00316 | |
| 0.065 | 0.023 | 0.065 | Myc inhibitor | |||
| 0.135 | 0.094 | 0.164 | Heat shock protein 70 antagonist | 0.164 0.023 DBMET00316 0.141 0.072 DBMET03178 0.147 0.053 DBMET03180 0.131 0.116 DBMET03181 | DBMET00316 | |
| 0.213 | 0.171 | 0.213 | Sodium/bile acid cotransporter inhibitor | |||
| 0.055 | 0.014 | 0.081 | TRPM8 blocker | 0.081 0.008 DBMET00316 0.051 0.015 DBMET03178 0.06 0.012 DBMET03180 0.05 0.016 DBMET03181 | DBMET00316 | |
| 0.07 | 0.029 | 0.08 | Cathepsin D inhibitor | 0.059 0.035 DBMET00316 0.08 0.025 DBMET03180 0.059 0.034 DBMET03181 | DBMET03180 | |
| 0.071 | 0.03 | 0.071 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.08 | 0.04 | 0.093 | Opioid mu receptor antagonist | 0.093 0.034 DBMET00316 | DBMET00316 | |
| 0.117 | 0.077 | 0.117 | Cholinergic antagonist | |||
| 0.093 | 0.054 | 0.141 | Aminoacyl-tRNA synthetase inhibitor | 0.097 0.048 DBMET00316 0.141 0.022 DBMET03181 | DBMET03181 | |
| 0.053 | 0.015 | 0.114 | Kinesin-like protein 1 inhibitor | 0.114 0.006 DBMET00316 | DBMET00316 | |
| 0.053 | 0.015 | 0.114 | Kinesin antagonist | 0.114 0.006 DBMET00316 | DBMET00316 | |
| 0.057 | 0.019 | 0.057 | Oxytocin agonist | 0.057 0.019 DBMET00316 | ||
| 0.137 | 0.099 | 0.279 | Growth hormone agonist | 0.279 0.037 DBMET00316 0.159 0.08 DBMET03179 0.126 0.111 DBMET03180 | DBMET00316 | |
| 0.133 | 0.096 | 0.234 | Phospholipase A2 inhibitor | 0.172 0.058 DBMET00316 0.234 0.028 DBMET03178 0.193 0.046 DBMET03180 0.158 0.067 DBMET03181 | DBMET03178 | |
| 0.134 | 0.097 | 0.134 | GABA C receptor rho-2 antagonist | 0.127 0.111 DBMET03178 | ||
| 0.055 | 0.018 | 0.065 | Histamine H2 receptor agonist | 0.065 0.012 DBMET00316 | DBMET00316 | |
| 0.045 | 0.009 | 0.073 | Tryptophan 5 hydroxylase inhibitor | 0.073 0.003 DBMET00316 0.045 0.008 DBMET03178 0.034 0.031 DBMET03179 0.045 0.009 DBMET03180 0.042 0.012 DBMET03181 | DBMET00316 | |
| 0.054 | 0.018 | 0.056 | Cathepsin L1 inhibitor | 0.056 0.017 DBMET00316 0.041 0.026 DBMET03178 | DBMET00316 | |
| 0.113 | 0.077 | 0.113 | Acetylcholine antagonist | |||
| 0.12 | 0.084 | 0.226 | Sodium channel (voltage-gated) blocker | 0.166 0.044 DBMET00316 0.132 0.071 DBMET03180 0.226 0.021 DBMET03181 | DBMET03181 | |
| 0.061 | 0.026 | 0.061 | Nicotinic alpha3beta2 receptor antagonist | 0.061 0.026 DBMET00316 0.053 0.037 DBMET03178 | ||
| 0.049 | 0.014 | 0.049 | Cathepsin F inhibitor | 0.043 0.024 DBMET00316 | ||
| 0.049 | 0.015 | 0.058 | Diamine oxidase inhibitor | 0.058 0.01 DBMET00316 0.044 0.019 DBMET03178 0.036 0.028 DBMET03181 | DBMET00316 | |
| 0.044 | 0.01 | 0.125 | Cholesterol ester transfer protein antagonist | 0.042 0.011 DBMET00316 0.066 0.004 DBMET03178 0.125 0.003 DBMET03180 0.115 0.003 DBMET03181 | DBMET03180 | |
| 0.051 | 0.017 | 0.051 | Plasmepsin II inhibitor | 0.042 0.027 DBMET00316 0.038 0.035 DBMET03180 | ||
| 0.044 | 0.01 | 0.071 | Lysophosphatidic acid 2 receptor antagonist | 0.04 0.012 DBMET00316 0.029 0.023 DBMET03178 0.05 0.009 DBMET03180 0.071 0.005 DBMET03181 | DBMET03181 | |
| 0.067 | 0.034 | 0.067 | Acetylcholine M3 receptor antagonist | |||
| 0.052 | 0.019 | 0.052 | Acetyl-CoA carboxylase inhibitor | |||
| 0.064 | 0.031 | 0.064 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.051 | 0.019 | 0.067 | Dipeptidyl peptidase IV inhibitor | 0.067 0.01 DBMET00316 | DBMET00316 | |
| 0.037 | 0.005 | 0.037 | Protease (Human cytomegalovirus) inhibitor | 0.036 0.005 DBMET00316 0.031 0.007 DBMET03178 | ||
| 0.098 | 0.066 | 0.105 | GABA C receptor rho-1 antagonist | 0.09 0.078 DBMET00316 0.105 0.056 DBMET03180 | DBMET03180 | |
| 0.11 | 0.079 | 0.13 | Transcription factor STAT6 inhibitor | 0.13 0.044 DBMET00316 | DBMET00316 | |
| 0.063 | 0.033 | 0.063 | Cathepsin B inhibitor | 0.056 0.039 DBMET00316 | ||
| 0.035 | 0.005 | 0.035 | Acid ceramidase inhibitor | 0.027 0.015 DBMET00316 0.03 0.009 DBMET03178 | ||
| 0.07 | 0.04 | 0.117 | Opioid delta receptor antagonist | 0.117 0.026 DBMET00316 | DBMET00316 | |
| 0.063 | 0.034 | 0.153 | Sphingosine kinase inhibitor | 0.116 0.005 DBMET00316 0.07 0.025 DBMET03178 0.153 0.004 DBMET03180 0.078 0.018 DBMET03181 | DBMET03180 | |
| 0.078 | 0.049 | 0.131 | Sphingosine 1-phosphate receptor antagonist | 0.094 0.026 DBMET00316 0.131 0.01 DBMET03178 0.108 0.017 DBMET03180 0.13 0.01 DBMET03181 | DBMET03178 | |
| 0.173 | 0.145 | 0.284 | Interleukin agonist | 0.265 0.068 DBMET00316 0.241 0.086 DBMET03180 0.284 0.056 DBMET03181 | DBMET03181 | |
| 0.059 | 0.031 | 0.124 | Sphingosine 1-phosphate receptor 1 antagonist | 0.078 0.014 DBMET00316 0.097 0.01 DBMET03178 0.1 0.009 DBMET03180 0.124 0.005 DBMET03181 | DBMET03181 | |
| 0.034 | 0.007 | 0.08 | Glutamate (mGluR1) agonist | 0.08 0.004 DBMET00316 0.024 0.017 DBMET03179 0.025 0.017 DBMET03180 | DBMET00316 | |
| 0.079 | 0.053 | 0.125 | Somatostatin 1 agonist | 0.125 0.021 DBMET00316 0.096 0.036 DBMET03181 | DBMET00316 | |
| 0.098 | 0.072 | 0.12 | Falcipain 3 inhibitor | 0.12 0.053 DBMET00316 | DBMET00316 | |
| 0.049 | 0.023 | 0.058 | Cathepsin L2 inhibitor | 0.058 0.019 DBMET00316 0.042 0.027 DBMET03178 | DBMET00316 | |
| 0.064 | 0.038 | 0.064 | Histone deacetylase SIRT3 inhibitor | 0.064 0.037 DBMET00316 | ||
| 0.03 | 0.005 | 0.03 | Microsomal triglyceride transfer protein inhibitor | 0.014 0.012 DBMET00316 0.019 0.008 DBMET03178 | ||
| 0.064 | 0.039 | 0.064 | Cannabinoid CB1 receptor agonist | |||
| 0.093 | 0.069 | 0.116 | MAO A inhibitor | 0.116 0.054 DBMET00316 | DBMET00316 | |
| 0.077 | 0.053 | 0.084 | Nicotinic alpha4beta2 receptor antagonist | 0.084 0.046 DBMET00316 | DBMET00316 | |
| 0.033 | 0.009 | 0.052 | Lysophosphatidic acid receptor 1 agonist | 0.029 0.012 DBMET00316 0.027 0.014 DBMET03178 0.051 0.004 DBMET03180 0.052 0.004 DBMET03181 | DBMET03181 | |
| 0.091 | 0.067 | 0.123 | Potassium channel (Voltage-sensitive) activator | 0.087 0.074 DBMET00316 0.123 0.029 DBMET03178 0.105 0.047 DBMET03180 0.09 0.067 DBMET03181 | DBMET03178 | |
| 0.04 | 0.017 | 0.049 | Ceramide glucosyltransferase inhibitor | 0.042 0.015 DBMET00316 0.033 0.03 DBMET03178 0.038 0.021 DBMET03180 0.049 0.007 DBMET03181 | DBMET03181 | |
| 0.082 | 0.058 | 0.105 | Glutathione S-transferase inhibitor | 0.105 0.033 DBMET00316 0.096 0.041 DBMET03178 0.074 0.073 DBMET03179 0.095 0.042 DBMET03180 0.092 0.046 DBMET03181 | DBMET00316 | |
| 0.059 | 0.035 | 0.065 | Human rhinovirus A protease inhibitor | 0.065 0.031 DBMET00316 0.057 0.037 DBMET03178 | DBMET00316 | |
| 0.037 | 0.014 | 0.037 | Vanilloid 4 antagonist | 0.032 0.023 DBMET00316 0.031 0.026 DBMET03180 | ||
| 0.2 | 0.177 | 0.292 | Antithrombotic | 0.232 0.141 DBMET00316 0.292 0.094 DBMET03180 0.261 0.118 DBMET03181 | DBMET03180 | |
| 0.042 | 0.019 | 0.052 | Delayed rectifier potassium channel blocker | 0.037 0.026 DBMET00316 0.052 0.01 DBMET03178 0.036 0.029 DBMET03180 | DBMET03178 | |
| 0.075 | 0.052 | 0.077 | Vanilloid 4 agonist | 0.07 0.066 DBMET00316 0.077 0.046 DBMET03180 | DBMET03180 | |
| 0.03 | 0.008 | 0.03 | Beta 1 adrenoreceptor agonist | 0.025 0.012 DBMET03180 0.026 0.011 DBMET03181 | ||
| 0.056 | 0.034 | 0.091 | Immunoglobulin Fc receptor antagonist | 0.067 0.014 DBMET00316 0.091 0.004 DBMET03179 0.068 0.013 DBMET03180 | DBMET03179 | |
| 0.073 | 0.052 | 0.084 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.084 0.029 DBMET00316 0.076 0.045 DBMET03179 | DBMET00316 | |
| 0.128 | 0.106 | 0.167 | Pregnane X receptor agonist | 0.134 0.088 DBMET00316 0.157 0.042 DBMET03178 0.149 0.055 DBMET03180 0.167 0.029 DBMET03181 | DBMET03181 | |
| 0.06 | 0.039 | 0.06 | Gonadotropin-releasing hormone receptor agonist | |||
| 0.054 | 0.034 | 0.054 | 5 Hydroxytryptamine 1B agonist | |||
| 0.068 | 0.047 | 0.068 | Alpha adrenoreceptor agonist | |||
| 0.036 | 0.016 | 0.036 | GHS receptor antagonist | |||
| 0.045 | 0.025 | 0.169 | Sphingosine 1-phosphate receptor 1 agonist | 0.066 0.01 DBMET00316 0.043 0.028 DBMET03178 0.169 0.003 DBMET03180 0.082 0.005 DBMET03181 | DBMET03180 | |
| 0.055 | 0.035 | 0.103 | Elastase inhibitor | 0.061 0.029 DBMET00316 0.103 0.009 DBMET03178 | DBMET03178 | |
| 0.05 | 0.031 | 0.065 | Glycine transporter inhibitor | 0.051 0.03 DBMET00316 0.05 0.031 DBMET03180 0.065 0.022 DBMET03181 | DBMET03181 | |
| 0.036 | 0.018 | 0.073 | Dipeptidyl peptidase II inhibitor | 0.073 0.005 DBMET00316 0.044 0.012 DBMET03179 | DBMET00316 | |
| 0.074 | 0.056 | 0.082 | Analgesic, opioid | 0.082 0.045 DBMET00316 | DBMET00316 | |
| 0.059 | 0.042 | 0.068 | Cathepsin E inhibitor | 0.062 0.037 DBMET00316 0.063 0.036 DBMET03180 0.068 0.031 DBMET03181 | DBMET03181 | |
| 0.034 | 0.018 | 0.065 | Peptide deformylase inhibitor | 0.044 0.013 DBMET03178 0.065 0.006 DBMET03179 | DBMET03179 | |
| 0.076 | 0.06 | 0.102 | Chymotrypsin inhibitor | 0.097 0.038 DBMET00316 0.086 0.047 DBMET03178 0.102 0.035 DBMET03180 | DBMET03180 | |
| 0.048 | 0.032 | 0.051 | Bombesin antagonist | 0.051 0.028 DBMET00316 | DBMET00316 | |
| 0.033 | 0.018 | 0.056 | Dipeptidyl peptidase I inhibitor | 0.056 0.007 DBMET00316 | DBMET00316 | |
| 0.03 | 0.015 | 0.035 | Motilin receptor antagonist | 0.035 0.01 DBMET00316 | DBMET00316 | |
| 0.085 | 0.07 | 0.099 | MAO B inhibitor | 0.099 0.06 DBMET00316 | DBMET00316 | |
| 0.036 | 0.021 | 0.046 | Growth hormone releasing factor agonist | 0.046 0.015 DBMET00316 | DBMET00316 | |
| 0.091 | 0.076 | 0.138 | Anabolic | 0.107 0.053 DBMET00316 0.133 0.029 DBMET03178 0.124 0.036 DBMET03180 0.138 0.025 DBMET03181 | DBMET03181 | |
| 0.024 | 0.01 | 0.024 | Apolipoprotein B inhibitor | |||
| 0.179 | 0.165 | 0.252 | Transcription factor STAT3 inhibitor | 0.252 0.082 DBMET00316 0.182 0.16 DBMET03178 0.182 0.161 DBMET03179 0.23 0.101 DBMET03180 0.178 0.167 DBMET03181 | DBMET00316 | |
| 0.058 | 0.044 | 0.058 | Ca(v)3.2 blocker | 0.058 0.042 DBMET03178 | ||
| 0.042 | 0.028 | 0.091 | Sphingosine kinase 1 inhibitor | 0.084 0.005 DBMET00316 0.045 0.022 DBMET03178 0.091 0.004 DBMET03180 0.052 0.015 DBMET03181 | DBMET03180 | |
| 0.067 | 0.053 | 0.067 | Cannabinoid receptor antagonist | |||
| 0.032 | 0.018 | 0.043 | Liver X receptor beta antagonist | 0.043 0.011 DBMET03178 0.04 0.013 DBMET03180 0.035 0.015 DBMET03181 | DBMET03178 | |
| 0.065 | 0.051 | 0.124 | Potassium channel large-conductance Ca-activated activator | 0.105 0.021 DBMET00316 0.092 0.028 DBMET03178 0.066 0.049 DBMET03179 0.124 0.015 DBMET03180 0.08 0.035 DBMET03181 | DBMET03180 | |
| 0.03 | 0.016 | 0.03 | LFA antagonist | 0.029 0.018 DBMET00316 0.028 0.019 DBMET03180 | ||
| 0.059 | 0.045 | 0.128 | Purinergic P2X1 antagonist | 0.092 0.019 DBMET00316 0.108 0.014 DBMET03178 0.058 0.047 DBMET03179 0.128 0.01 DBMET03180 0.114 0.013 DBMET03181 | DBMET03180 | |
| 0.056 | 0.043 | 0.064 | Dopamine uptake inhibitor | 0.064 0.035 DBMET00316 | DBMET00316 | |
| 0.037 | 0.025 | 0.079 | Histone deacetylase 7 inhibitor | 0.043 0.021 DBMET03178 0.079 0.011 DBMET03179 | DBMET03179 | |
| 0.055 | 0.043 | 0.084 | Pregnane X receptor antagonist | 0.064 0.023 DBMET00316 0.084 0.005 DBMET03178 0.079 0.007 DBMET03180 0.081 0.006 DBMET03181 | DBMET03178 | |
| 0.121 | 0.109 | 0.252 | Insulin secretagoues | 0.117 0.115 DBMET00316 0.252 0.019 DBMET03180 0.185 0.044 DBMET03181 | DBMET03180 | |
| 0.034 | 0.022 | 0.034 | Calpain 1 inhibitor | |||
| 0.046 | 0.034 | 0.047 | Baculoviral IAP repeat-containing protein inhibitor | 0.047 0.03 DBMET00316 | DBMET00316 | |
| 0.088 | 0.076 | 0.088 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.044 | 0.032 | 0.063 | Dihydroorotase inhibitor | 0.057 0.018 DBMET00316 0.063 0.014 DBMET03178 0.045 0.03 DBMET03180 | DBMET03178 | |
| 0.102 | 0.091 | 0.163 | Interleukin 8 antagonist | 0.163 0.026 DBMET00316 0.121 0.06 DBMET03178 0.109 0.078 DBMET03180 | DBMET00316 | |
| 0.04 | 0.029 | 0.046 | Erythropoietin receptor agonist | 0.046 0.024 DBMET00316 | DBMET00316 | |
| 0.022 | 0.012 | 0.026 | Neuraminidase (Influenza B) inhibitor | 0.022 0.013 DBMET00316 0.026 0.007 DBMET03180 0.024 0.009 DBMET03181 | DBMET03180 | |
| 0.042 | 0.032 | 0.099 | Glutamate (mGluR4) antagonist | 0.083 0.008 DBMET00316 0.099 0.005 DBMET03179 | DBMET03179 | |
| 0.038 | 0.029 | 0.054 | Histone deacetylase 9 inhibitor | 0.044 0.02 DBMET03178 0.054 0.014 DBMET03179 | DBMET03179 | |
| 0.058 | 0.048 | 0.058 | Cannabinoid CB1 receptor antagonist | |||
| 0.088 | 0.078 | 0.189 | Electrolyte absorption antagonist | 0.091 0.073 DBMET00316 0.108 0.047 DBMET03178 0.189 0.01 DBMET03180 0.127 0.031 DBMET03181 | DBMET03180 | |
| 0.037 | 0.028 | 0.042 | Melanocortin 1 antagonist | 0.042 0.023 DBMET00316 | DBMET00316 | |
| 0.031 | 0.022 | 0.045 | Endothelial nitric-oxide synthase inhibitor | 0.045 0.011 DBMET00316 | DBMET00316 | |
| 0.044 | 0.036 | 0.044 | Melanocortin antagonist | 0.043 0.038 DBMET00316 | ||
| 0.023 | 0.015 | 0.029 | ICAM 1 antagonist | 0.028 0.008 DBMET00316 0.029 0.007 DBMET03180 | DBMET03180 | |
| 0.068 | 0.06 | 0.15 | Nav1.8 sodium channel blocker | 0.15 0.014 DBMET00316 0.068 0.059 DBMET03178 0.074 0.05 DBMET03180 | DBMET00316 | |
| 0.089 | 0.081 | 0.141 | GABA C receptor agonist | 0.141 0.038 DBMET00316 0.123 0.048 DBMET03178 0.124 0.047 DBMET03180 0.088 0.081 DBMET03181 | DBMET00316 | |
| 0.04 | 0.032 | 0.04 | Melanocortin 4 antagonist | 0.037 0.035 DBMET00316 | ||
| 0.038 | 0.032 | 0.038 | CC chemokine 3 receptor antagonist | |||
| 0.067 | 0.06 | 0.129 | Peroxisome proliferator-activated receptor gamma antagonist | 0.072 0.049 DBMET00316 0.086 0.027 DBMET03178 0.129 0.008 DBMET03180 0.1 0.015 DBMET03181 | DBMET03180 | |
| 0.058 | 0.052 | 0.058 | DNA gyrase inhibitor | |||
| 0.041 | 0.036 | 0.164 | Sphingosine 1-phosphate receptor agonist | 0.062 0.015 DBMET00316 0.04 0.037 DBMET03178 0.164 0.004 DBMET03180 0.083 0.008 DBMET03181 | DBMET03180 | |
| 0.028 | 0.023 | 0.028 | Vasopressin 1A agonist | |||
| 0.014 | 0.009 | 0.036 | Lysophosphatidic acid receptor 3 agonist | 0.015 0.008 DBMET00316 0.013 0.009 DBMET03178 0.029 0.004 DBMET03180 0.036 0.003 DBMET03181 | DBMET03181 | |
| 0.027 | 0.022 | 0.037 | Thrombin receptor antagonist | 0.037 0.013 DBMET00316 | DBMET00316 | |
| 0.077 | 0.072 | 0.077 | Histamine H2 receptor antagonist | |||
| 0.018 | 0.013 | 0.018 | Apolipoprotein B-100 inhibitor | |||
| 0.113 | 0.108 | 0.211 | Neurotrophic factor | 0.135 0.074 DBMET00316 0.211 0.023 DBMET03178 0.142 0.066 DBMET03180 0.121 0.093 DBMET03181 | DBMET03178 | |
| 0.04 | 0.036 | 0.052 | Nerve growth factor antagonist | 0.051 0.017 DBMET00316 0.052 0.015 DBMET03178 0.044 0.027 DBMET03180 | DBMET03178 | |
| 0.054 | 0.05 | 0.08 | Androgen agonist | 0.053 0.052 DBMET00316 0.08 0.024 DBMET03178 0.071 0.029 DBMET03180 0.078 0.025 DBMET03181 | DBMET03178 | |
| 0.02 | 0.017 | 0.02 | Acetyl-CoA carboxylase 2 inhibitor | |||
| 0.053 | 0.049 | 0.075 | Carbonic anhydrase stimulant | 0.075 0.028 DBMET00316 | DBMET00316 | |
| 0.046 | 0.043 | 0.055 | Prolyl endopeptidase inhibitor | 0.055 0.03 DBMET00316 0.049 0.038 DBMET03178 | DBMET00316 | |
| 0.019 | 0.016 | 0.019 | Integrin alpha4beta7 antagonist | |||
| 0.018 | 0.015 | 0.027 | Growth hormone release promoting | 0.027 0.011 DBMET00316 | DBMET00316 | |
| 0.079 | 0.077 | 0.163 | Potassium channel (Ca-activated) activator | 0.14 0.031 DBMET00316 0.114 0.045 DBMET03178 0.082 0.073 DBMET03179 0.163 0.024 DBMET03180 0.097 0.058 DBMET03181 | DBMET03180 | |
| 0.032 | 0.03 | 0.041 | Opioid delta receptor agonist | 0.041 0.018 DBMET00316 | DBMET00316 | |
| 0.026 | 0.024 | 0.027 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.027 0.019 DBMET00316 | DBMET00316 | |
| 0.066 | 0.064 | 0.126 | Metalloproteinase-9 inhibitor | 0.126 0.023 DBMET03179 | DBMET03179 | |
| 0.041 | 0.04 | 0.041 | Antimetabolite | 0.041 0.039 DBMET00316 | ||
| 0.134 | 0.133 | 0.212 | 3C-like protease (Human coronavirus) inhibitor | 0.188 0.059 DBMET00316 0.212 0.045 DBMET03178 0.176 0.069 DBMET03180 | DBMET03178 | |
| 0.043 | 0.042 | 0.043 | Cannabinoid CB2 receptor antagonist | |||
| 0.058 | 0.058 | 0.076 | Aryl hydrocarbon receptor antagonist | 0.07 0.037 DBMET00316 0.076 0.031 DBMET03178 0.075 0.031 DBMET03180 0.066 0.043 DBMET03181 | DBMET03178 | |
| 0.045 | 0.045 | 0.108 | Neuropeptide agonist | 0.108 0.025 DBMET00316 0.085 0.03 DBMET03180 0.063 0.037 DBMET03181 | DBMET00316 | |
| 0.084 | 0.084 | 0.134 | Lanosterol 14 alpha demethylase inhibitor | 0.118 0.032 DBMET00316 0.134 0.019 DBMET03178 0.131 0.021 DBMET03180 0.133 0.019 DBMET03181 | DBMET03178 | |
| 0.039 | 0.039 | 0.041 | Geranyltranstransferase inhibitor | 0.041 0.034 DBMET03180 | DBMET03180 | |
| 0.016 | 0.016 | 0.027 | Tryptophan hydroxylase 1 inhibitor | 0.027 0.004 DBMET00316 | DBMET00316 | |
| 0.026 | 0.026 | 0.027 | Plasmepsin I inhibitor | 0.027 0.026 DBMET03180 | DBMET03180 | |
| 0.037 | 0.038 | 0.047 | Leukocyte elastase inhibitor | 0.047 0.026 DBMET00316 0.047 0.025 DBMET03178 | DBMET03178 | |
| 0.026 | 0.026 | 0.03 | Liver X receptor alpha antagonist | 0.029 0.02 DBMET03178 0.03 0.019 DBMET03180 | DBMET03180 | |
| 0.035 | 0.035 | 0.04 | Secretase gamma inhibitor | 0.04 0.032 DBMET03178 | DBMET03178 | |
| 0.072 | 0.075 | 0.201 | Androgen antagonist | 0.201 0.013 DBMET03178 0.158 0.02 DBMET03180 0.172 0.017 DBMET03181 | DBMET03178 | |
| 0.044 | 0.047 | 0.186 | Collagenase inhibitor | 0.186 0.004 DBMET03179 | DBMET03179 | |
| 0.091 | 0.095 | 0.166 | DOPA decarboxylase inhibitor | 0.166 0.014 DBMET00316 0.16 0.017 DBMET03178 0.095 0.086 DBMET03179 0.114 0.053 DBMET03180 | DBMET00316 | |
| 0.051 | 0.055 | 0.073 | Bombesin 1 receptor agonist | 0.073 0.029 DBMET00316 | DBMET00316 | |
| 0.016 | 0.019 | 0.021 | Neurokinin 1 agonist | 0.021 0.014 DBMET00316 | DBMET00316 | |
| 0.056 | 0.061 | 0.078 | Acetylcholine M5 receptor agonist | 0.078 0.036 DBMET03178 | DBMET03178 | |
| 0.03 | 0.036 | 0.057 | AMPA receptor agonist | 0.05 0.009 DBMET00316 0.057 0.006 DBMET03178 | DBMET03178 | |
| 0.03 | 0.035 | 0.04 | Potassium channel KCNQ activator | 0.039 0.023 DBMET03178 0.04 0.022 DBMET03180 | DBMET03180 | |
| 0.03 | 0.035 | 0.04 | Delayed rectifier potassium channel activator | 0.039 0.023 DBMET03178 0.04 0.022 DBMET03180 | DBMET03180 | |
| 0.027 | 0.032 | 0.04 | Calcitonin receptor agonist | 0.04 0.02 DBMET00316 0.034 0.023 DBMET03180 0.03 0.027 DBMET03181 | DBMET00316 | |
| 0.019 | 0.024 | 0.022 | Bombesin agonist | 0.022 0.016 DBMET00316 | DBMET00316 | |
| 0.071 | 0.077 | 0.073 | Neuropeptide Y antagonist | 0.073 0.072 DBMET00316 | DBMET00316 | |
| 0.028 | 0.035 | 0.031 | Carboxypeptidase B inhibitor | 0.031 0.027 DBMET00316 | DBMET00316 | |
| 0.046 | 0.053 | 0.074 | Matrix metalloproteinase (membrane-type) inhibitor | 0.074 0.022 DBMET03179 | DBMET03179 | |
| 0.041 | 0.048 | 0.046 | Ribonucleoside-diphosphate reductase inhibitor | 0.045 0.044 DBMET00316 0.046 0.044 DBMET03179 | DBMET03179 | |
| 0.047 | 0.054 | 0.061 | Bombesin 3 receptor antagonist | 0.061 0.032 DBMET00316 | DBMET00316 | |
| 0.012 | 0.02 | 0.023 | Aminopeptidase A inhibitor | 0.02 0.01 DBMET00316 0.023 0.009 DBMET03179 | DBMET03179 | |
| 0.024 | 0.032 | 0.029 | Trypsin II inhibitor | 0.029 0.022 DBMET00316 | DBMET00316 | |
| 0.017 | 0.026 | 0.032 | Aminopeptidase P inhibitor | 0.032 0.008 DBMET00316 | DBMET00316 | |
| 0.024 | 0.033 | 0.031 | Liver X receptor antagonist | 0.029 0.024 DBMET03178 0.031 0.022 DBMET03180 | DBMET03180 | |
| 0.035 | 0.044 | 0.059 | HIV-1 protease inhibitor | 0.059 0.013 DBMET03180 0.045 0.027 DBMET03181 | DBMET03180 | |
| 0.015 | 0.024 | 0.018 | Bombesin 3 receptor agonist | 0.018 0.016 DBMET00316 | DBMET00316 | |
| 0.022 | 0.031 | 0.033 | Calcium-sensing receptor agonist | 0.033 0.011 DBMET00316 | DBMET00316 | |
| 0.038 | 0.047 | 0.088 | Glutamate (mGluR group III) antagonist | 0.088 0.006 DBMET00316 0.041 0.037 DBMET03178 0.086 0.007 DBMET03179 | DBMET00316 | |
| 0.081 | 0.09 | 0.108 | Carbonic anhydrase III inhibitor | 0.108 0.054 DBMET00316 0.099 0.063 DBMET03179 | DBMET00316 | |
| 0.032 | 0.042 | 0.07 | Glutamate (mGluR8) agonist | 0.07 0.005 DBMET00316 0.043 0.018 DBMET03178 0.035 0.034 DBMET03179 0.045 0.016 DBMET03180 0.038 0.026 DBMET03181 | DBMET00316 | |
| 0.021 | 0.031 | 0.028 | Thyroid hormone agonist | 0.028 0.015 DBMET00316 0.027 0.016 DBMET03178 | DBMET00316 | |
| 0.054 | 0.064 | 0.084 | Vanilloid 1 antagonist | 0.067 0.047 DBMET03178 0.084 0.034 DBMET03180 | DBMET03180 | |
| 0.06 | 0.07 | 0.067 | Thrombin inhibitor | 0.067 0.058 DBMET00316 | DBMET00316 | |
| 0.024 | 0.034 | 0.04 | Sirtuin 2 inhibitor | 0.04 0.018 DBMET00316 | DBMET00316 | |
| 0.041 | 0.051 | 0.055 | Opioid agonist | 0.055 0.034 DBMET00316 | DBMET00316 | |
| 0.048 | 0.059 | 0.062 | Kallikrein 1 inhibitor | 0.062 0.031 DBMET00316 | DBMET00316 | |
| 0.033 | 0.044 | 0.066 | Liver X receptor alpha agonist | 0.055 0.015 DBMET03178 0.066 0.01 DBMET03180 0.052 0.018 DBMET03181 | DBMET03180 | |
| 0.024 | 0.036 | 0.029 | Estrogen-related receptor gamma antagonist | 0.029 0.019 DBMET03178 0.029 0.017 DBMET03180 0.026 0.025 DBMET03181 | DBMET03180 | |
| 0.036 | 0.048 | 0.063 | Opioid mu receptor agonist | 0.063 0.022 DBMET00316 | DBMET00316 | |
| 0.187 | 0.199 | 0.353 | Apoptosis antagonist | 0.242 0.136 DBMET00316 0.353 0.054 DBMET03178 0.271 0.107 DBMET03180 0.198 0.182 DBMET03181 | DBMET03178 | |
| 0.053 | 0.066 | 0.062 | Caspase 9 inhibitor | 0.057 0.055 DBMET00316 0.062 0.043 DBMET03178 | DBMET03178 | |
| 0.027 | 0.041 | 0.038 | Glutamate (mGluR3) agonist | 0.038 0.012 DBMET00316 | DBMET00316 | |
| 0.015 | 0.029 | 0.018 | Alpha 2b adrenoreceptor agonist | 0.018 0.015 DBMET03181 | DBMET03181 | |
| 0.025 | 0.04 | 0.062 | Retinoid X alpha receptor agonist | 0.032 0.027 DBMET00316 0.052 0.013 DBMET03178 0.062 0.011 DBMET03180 0.033 0.026 DBMET03181 | DBMET03180 | |
| 0.171 | 0.185 | 0.255 | Transcription factor STAT inhibitor | 0.255 0.083 DBMET00316 0.205 0.131 DBMET03180 | DBMET00316 | |
| 0.042 | 0.056 | 0.071 | Plasminogen activator inhibitor | 0.071 0.031 DBMET00316 | DBMET00316 | |
| 0.047 | 0.062 | 0.055 | Calcium channel T-type blocker | 0.055 0.045 DBMET03178 | DBMET03178 | |
| 0.075 | 0.09 | 0.092 | Granulocyte macrophage colony stimulating factor agonist | 0.092 0.047 DBMET00316 0.08 0.075 DBMET03178 | DBMET00316 | |
| 0.06 | 0.075 | 0.07 | Protein kinase B gamma inhibitor | 0.07 0.058 DBMET00316 | DBMET00316 | |
| 0.017 | 0.032 | 0.063 | Prostaglandin F2 alpha agonist | 0.031 0.008 DBMET03178 0.063 0.003 DBMET03180 0.055 0.004 DBMET03181 | DBMET03180 | |
| 0.029 | 0.044 | 0.121 | Glutamate (mGluR3) antagonist | 0.121 0.004 DBMET00316 0.043 0.017 DBMET03178 0.038 0.023 DBMET03179 0.063 0.008 DBMET03180 0.033 0.032 DBMET03181 | DBMET00316 | |
| 0.029 | 0.044 | 0.047 | Toll-Like receptor 2 agonist | 0.047 0.025 DBMET00316 0.04 0.03 DBMET03180 0.037 0.032 DBMET03181 | DBMET00316 | |
| 0.003 | 0.019 | 0.006 | CC chemokine 6 receptor agonist | 0.006 0.005 DBMET00316 | DBMET00316 | |
| 0.034 | 0.05 | 0.053 | Liver X receptor agonist | 0.045 0.029 DBMET03178 0.053 0.02 DBMET03180 0.044 0.03 DBMET03181 | DBMET03180 | |
| 0.03 | 0.046 | 0.045 | Dopamine D5 agonist | 0.045 0.021 DBMET00316 0.041 0.026 DBMET03178 | DBMET00316 | |
| 0.089 | 0.105 | 0.134 | Beta amyloid protein antagonist | 0.134 0.054 DBMET00316 0.105 0.083 DBMET03180 | DBMET00316 | |
| 0.046 | 0.062 | 0.138 | 5 Hydroxytryptamine uptake inhibitor | 0.069 0.04 DBMET00316 0.138 0.017 DBMET03179 | DBMET03179 | |
| 0.163 | 0.18 | 0.261 | DNA synthesis inhibitor | 0.177 0.157 DBMET00316 0.261 0.06 DBMET03180 0.194 0.133 DBMET03181 | DBMET03180 | |
| 0.057 | 0.075 | 0.176 | Glutamate decarboxylase inhibitor | 0.134 0.017 DBMET00316 0.106 0.026 DBMET03178 0.176 0.009 DBMET03179 0.132 0.017 DBMET03180 0.161 0.011 DBMET03181 | DBMET03179 | |
| 0.034 | 0.053 | 0.056 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.056 0.01 DBMET00316 0.053 0.012 DBMET03178 0.05 0.014 DBMET03180 0.045 0.021 DBMET03181 | DBMET00316 | |
| 0.018 | 0.037 | 0.026 | Urotensin II agonist | 0.026 0.019 DBMET00316 | DBMET00316 | |
| 0.019 | 0.039 | 0.165 | Histone deacetylase 4 inhibitor | 0.165 0.004 DBMET03179 | DBMET03179 | |
| 0.047 | 0.066 | 0.093 | Adrenaline uptake inhibitor | 0.093 0.021 DBMET00316 | DBMET00316 | |
| 0.018 | 0.038 | 0.061 | Glucagon receptor antagonist | 0.042 0.013 DBMET03180 0.061 0.008 DBMET03181 | DBMET03181 | |
| 0.017 | 0.038 | 0.122 | Prostaglandin EP4 antagonist | 0.122 0.004 DBMET03180 0.073 0.005 DBMET03181 | DBMET03180 | |
| 0.028 | 0.048 | 0.108 | Histone deacetylase 8 inhibitor | 0.108 0.008 DBMET03179 | DBMET03179 | |
| 0.045 | 0.066 | 0.1 | Dihydroorotate oxidase inhibitor | 0.058 0.032 DBMET00316 0.1 0.005 DBMET03178 0.08 0.01 DBMET03179 0.081 0.01 DBMET03180 0.076 0.013 DBMET03181 | DBMET03178 | |
| 0.021 | 0.042 | 0.043 | Arginase inhibitor | 0.043 0.019 DBMET00316 | DBMET00316 | |
| 0.1 | 0.121 | 0.15 | Histone deacetylase SIRT1 inhibitor | 0.15 0.061 DBMET00316 | DBMET00316 | |
| 0.084 | 0.106 | 0.161 | Mucolytic | 0.128 0.047 DBMET00316 0.126 0.049 DBMET03178 0.141 0.038 DBMET03180 0.161 0.027 DBMET03181 | DBMET03181 | |
| 0.028 | 0.05 | 0.036 | Vascular adhesion protein 1 inhibitor | 0.036 0.031 DBMET03181 | DBMET03181 | |
| 0.089 | 0.112 | 0.112 | CDK3/cyclin E inhibitor | 0.112 0.066 DBMET03179 | DBMET03179 | |
| 0.016 | 0.039 | 0.029 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.025 0.007 DBMET03178 0.029 0.005 DBMET03180 | DBMET03180 | |
| 0.043 | 0.066 | 0.074 | Glucagon-like peptide 1 agonist | 0.074 0.039 DBMET00316 | DBMET00316 | |
| 0.14 | 0.164 | 0.194 | Immunostimulant | 0.194 0.124 DBMET00316 0.189 0.127 DBMET03180 0.173 0.137 DBMET03181 | DBMET00316 | |
| 0.014 | 0.038 | 0.049 | Glutamate (mGluR1a) agonist | 0.049 0.005 DBMET00316 0.021 0.017 DBMET03178 | DBMET00316 | |
| 0.03 | 0.055 | 0.038 | Neurokinin 2 agonist | 0.038 0.034 DBMET00316 | DBMET00316 | |
| 0.192 | 0.218 | 0.296 | GABA C receptor rho-3 antagonist | 0.206 0.2 DBMET00316 0.296 0.119 DBMET03178 | DBMET03178 | |
| 0.072 | 0.098 | 0.224 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.169 0.022 DBMET00316 0.141 0.03 DBMET03178 0.224 0.012 DBMET03180 0.148 0.027 DBMET03181 | DBMET03180 | |
| 0.074 | 0.1 | 0.1 | 5 Hydroxytryptamine 2 antagonist | 0.1 0.071 DBMET00316 | DBMET00316 | |
| 0.014 | 0.04 | 0.029 | Methionyl aminopeptidase 2 inhibitor | 0.029 0.014 DBMET00316 0.026 0.017 DBMET03180 | DBMET00316 | |
| 0.021 | 0.048 | 0.032 | 5 Hydroxytryptamine 6 agonist | 0.032 0.014 DBMET00316 | DBMET00316 | |
| 0.033 | 0.06 | 0.055 | GABA B receptor antagonist | 0.053 0.017 DBMET00316 0.05 0.019 DBMET03178 0.055 0.015 DBMET03180 0.045 0.025 DBMET03181 | DBMET03180 | |
| 0.008 | 0.036 | 0.053 | Calcium-sensing receptor antagonist | 0.032 0.006 DBMET03180 0.053 0.005 DBMET03181 | DBMET03181 | |
| 0.03 | 0.058 | 0.079 | Aggrecanase 1 inhibitor | 0.079 0.005 DBMET03179 | DBMET03179 | |
| 0.018 | 0.046 | 0.026 | Vanilloid 2 agonist | 0.026 0.016 DBMET00316 0.024 0.02 DBMET03178 | DBMET00316 | |
| 0.038 | 0.066 | 0.177 | Aminopeptidase microsomal inhibitor | 0.073 0.029 DBMET00316 0.177 0.005 DBMET03179 | DBMET03179 | |
| 0.045 | 0.074 | 0.106 | Matrix metalloproteinase inhibitor | 0.106 0.024 DBMET03179 | DBMET03179 | |
| 0.012 | 0.042 | 0.018 | CXC chemokine 5 receptor antagonist | 0.018 0.013 DBMET03180 | DBMET03180 | |
| 0.044 | 0.074 | 0.055 | 5 Hydroxytryptamine 7 agonist | 0.055 0.04 DBMET00316 | DBMET00316 | |
| 0.063 | 0.093 | 0.106 | NMDA receptor antagonist | 0.106 0.043 DBMET00316 | DBMET00316 | |
| 0.031 | 0.062 | 0.041 | Glucagon-like peptide 1 receptor antagonist | 0.039 0.029 DBMET00316 0.04 0.026 DBMET03180 0.041 0.024 DBMET03181 | DBMET03181 | |
| 0.032 | 0.064 | 0.061 | Kainate receptor agonist | 0.061 0.006 DBMET00316 | DBMET00316 | |
| 0.021 | 0.053 | 0.051 | Liver X receptor beta agonist | 0.035 0.02 DBMET03178 0.051 0.01 DBMET03180 0.04 0.015 DBMET03181 | DBMET03180 | |
| 0.053 | 0.086 | 0.113 | Glutamate (mGluR7) antagonist | 0.113 0.005 DBMET00316 0.1 0.011 DBMET03178 0.093 0.015 DBMET03180 0.073 0.037 DBMET03181 | DBMET00316 | |
| 0.058 | 0.091 | 0.134 | Metalloproteinase-2 inhibitor | 0.134 0.024 DBMET03179 | DBMET03179 | |
| 0.024 | 0.057 | 0.217 | Peroxisome proliferator-activated receptor delta antagonist | 0.037 0.017 DBMET03178 0.217 0.004 DBMET03180 0.037 0.018 DBMET03181 | DBMET03180 | |
| 0.086 | 0.119 | 0.194 | TRPA1 agonist | 0.11 0.072 DBMET00316 0.194 0.012 DBMET03178 0.179 0.016 DBMET03180 0.123 0.055 DBMET03181 | DBMET03178 | |
| 0.052 | 0.086 | 0.096 | Cathepsin G inhibitor | 0.096 0.035 DBMET00316 0.064 0.063 DBMET03180 | DBMET00316 | |
| 0.028 | 0.062 | 0.046 | Calcium-independent phospholipase A2 inhibitor | 0.046 0.005 DBMET03178 | DBMET03178 | |
| 0.018 | 0.052 | 0.151 | Histone deacetylase 11 inhibitor | 0.151 0.004 DBMET03179 | DBMET03179 | |
| 0.018 | 0.052 | 0.151 | Histone deacetylase class IV inhibitor | 0.151 0.004 DBMET03179 | DBMET03179 | |
| 0.019 | 0.054 | 0.039 | Purinergic P2Y14 antagonist | 0.038 0.013 DBMET03178 0.035 0.015 DBMET03180 0.039 0.012 DBMET03181 | DBMET03181 | |
| 0.05 | 0.085 | 0.103 | Protein kinase B alpha inhibitor | 0.103 0.029 DBMET00316 | DBMET00316 | |
| 0.054 | 0.09 | 0.115 | Glutamate dehydrogenase inhibitor | 0.106 0.028 DBMET00316 0.102 0.029 DBMET03178 0.115 0.024 DBMET03180 0.097 0.032 DBMET03181 | DBMET03180 | |
| 0.031 | 0.067 | 0.064 | Ornithine carbamoyltransferase inhibitor | 0.064 0.029 DBMET00316 | DBMET00316 | |
| 0.014 | 0.051 | 0.06 | Sphingosine 1-phosphate receptor 3 agonist | 0.06 0.012 DBMET03180 0.054 0.014 DBMET03181 | DBMET03180 | |
| 0.046 | 0.082 | 0.082 | Transcription factor AP-1 inhibitor | 0.082 0.02 DBMET03178 0.064 0.038 DBMET03180 | DBMET03178 | |
| 0.028 | 0.065 | 0.039 | AMPA 4 receptor antagonist | 0.039 0.028 DBMET00316 | DBMET00316 | |
| 0.08 | 0.117 | 0.174 | Adenylate kinase inhibitor | 0.129 0.037 DBMET00316 0.165 0.022 DBMET03178 0.091 0.084 DBMET03179 0.171 0.02 DBMET03180 0.174 0.019 DBMET03181 | DBMET03181 | |
| 0.026 | 0.064 | 0.157 | Aminopeptidase N inhibitor | 0.054 0.028 DBMET00316 0.157 0.005 DBMET03179 | DBMET03179 | |
| 0.034 | 0.072 | 0.06 | Cholesterol esterase inhibitor | 0.06 0.018 DBMET03178 0.056 0.021 DBMET03180 0.058 0.019 DBMET03181 | DBMET03178 | |
| 0.02 | 0.058 | 0.049 | Free fatty acid receptor 1 antagonist | 0.031 0.029 DBMET00316 0.049 0.009 DBMET03178 0.047 0.011 DBMET03180 | DBMET03178 | |
| 0.008 | 0.047 | 0.019 | Dipeptidyl peptidase VIII inhibitor | 0.019 0.008 DBMET00316 | DBMET00316 | |
| 0.042 | 0.08 | 0.079 | Botulinum neurotoxin type A inhibitor | 0.054 0.048 DBMET00316 0.079 0.018 DBMET03179 | DBMET03179 | |
| 0.021 | 0.059 | 0.03 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.03 0.012 DBMET03180 | DBMET03180 | |
| 0.054 | 0.093 | 0.119 | Calcium channel P-type blocker | 0.063 0.046 DBMET00316 0.075 0.021 DBMET03178 0.119 0.004 DBMET03180 0.081 0.014 DBMET03181 | DBMET03180 | |
| 0.079 | 0.118 | 0.137 | Nav1.4 sodium channel blocker | 0.137 0.04 DBMET00316 | DBMET00316 | |
| 0.029 | 0.069 | 0.054 | Phenylethanolamine N methyltransferase inhibitor | 0.054 0.011 DBMET00316 | DBMET00316 | |
| 0.041 | 0.081 | 0.108 | Neutrophil collagenase inhibitor | 0.06 0.051 DBMET00316 0.108 0.019 DBMET03179 | DBMET03179 | |
| 0.012 | 0.052 | 0.019 | Progesterone receptor B antagonist | 0.019 0.014 DBMET03178 | DBMET03178 | |
| 0.105 | 0.145 | 0.126 | Aurora-C kinase inhibitor | 0.122 0.102 DBMET03180 0.126 0.091 DBMET03181 | DBMET03181 | |
| 0.085 | 0.125 | 0.127 | Photosensitizer | 0.119 0.058 DBMET00316 0.127 0.05 DBMET03178 0.1 0.088 DBMET03180 | DBMET03178 | |
| 0.037 | 0.079 | 0.046 | Cytokine production stimulant | 0.046 0.043 DBMET00316 | DBMET00316 | |
| 0.019 | 0.061 | 0.037 | Complement C3a chemotactic receptor antagonist | 0.037 0.034 DBMET00316 | DBMET00316 | |
| 0.209 | 0.252 | 0.269 | MAP kinase kinase 6 inhibitor | 0.269 0.168 DBMET00316 0.261 0.176 DBMET03178 | DBMET00316 | |
| 0.026 | 0.068 | 0.148 | Peroxisome proliferator-activated receptor alpha agonist | 0.05 0.032 DBMET03178 0.148 0.006 DBMET03180 0.085 0.016 DBMET03181 | DBMET03180 | |
| 0.028 | 0.071 | 0.039 | Nicotinic receptor alpha3 subunit antagonist | 0.039 0.037 DBMET00316 | DBMET00316 | |
| 0.008 | 0.052 | 0.024 | Dipeptidyl peptidase IX inhibitor | 0.024 0.007 DBMET00316 | DBMET00316 | |
| 0.026 | 0.069 | 0.057 | NMDA 2A receptor antagonist | 0.057 0.032 DBMET00316 | DBMET00316 | |
| 0.025 | 0.069 | 0.04 | Growth hormone release inhibitor | 0.04 0.031 DBMET00316 0.038 0.034 DBMET03181 | DBMET00316 | |
| 0.067 | 0.111 | 0.112 | NADH dehydrogenase inhibitor | 0.112 0.033 DBMET03180 0.109 0.036 DBMET03181 | DBMET03180 | |
| 0.066 | 0.111 | 0.138 | Alcohol dehydrogenase inhibitor | 0.119 0.035 DBMET00316 0.138 0.025 DBMET03178 0.135 0.026 DBMET03180 0.095 0.058 DBMET03181 | DBMET03178 | |
| 0.016 | 0.061 | 0.08 | Retinoid X receptor agonist | 0.041 0.022 DBMET03178 0.08 0.008 DBMET03180 0.038 0.024 DBMET03181 | DBMET03180 | |
| 0.032 | 0.077 | 0.043 | CF transmembrane conductance regulator antagonist | 0.043 0.018 DBMET03178 0.038 0.034 DBMET03180 0.038 0.033 DBMET03181 | DBMET03178 | |
| 0.01 | 0.055 | 0.016 | Vitamin D receptor agonist | 0.015 0.014 DBMET03180 0.016 0.012 DBMET03181 | DBMET03181 | |
| 0.016 | 0.062 | 0.129 | Peroxisome proliferator-activated receptor delta agonist | 0.041 0.017 DBMET03178 0.129 0.004 DBMET03180 0.042 0.016 DBMET03181 | DBMET03180 | |
| 0.085 | 0.131 | 0.135 | Cyclooxygenase 3 inhibitor | 0.119 0.078 DBMET00316 0.105 0.095 DBMET03178 0.134 0.063 DBMET03180 0.135 0.062 DBMET03181 | DBMET03181 | |
| 0.03 | 0.076 | 0.046 | Neuraminidase (Influenza A) inhibitor | 0.046 0.031 DBMET03180 0.045 0.032 DBMET03181 | DBMET03180 | |
| 0.111 | 0.157 | 0.237 | Melanin inhibitor | 0.153 0.077 DBMET00316 0.182 0.05 DBMET03178 0.143 0.092 DBMET03179 0.182 0.05 DBMET03180 0.237 0.031 DBMET03181 | DBMET03181 | |
| 0.023 | 0.07 | 0.04 | Purinergic P2Y antagonist | 0.04 0.037 DBMET03180 | DBMET03180 | |
| 0.027 | 0.075 | 0.033 | Adenosine uptake inhibitor | 0.033 0.031 DBMET00316 0.033 0.031 DBMET03178 | DBMET03178 | |
| 0.175 | 0.223 | 0.388 | Immunosuppressant | 0.278 0.129 DBMET00316 0.305 0.112 DBMET03178 0.251 0.147 DBMET03179 0.336 0.094 DBMET03180 0.388 0.068 DBMET03181 | DBMET03181 | |
| 0.032 | 0.08 | 0.08 | Acyl-CoA dehydrogenase inhibitor | 0.049 0.044 DBMET03178 0.08 0.022 DBMET03180 0.069 0.027 DBMET03181 | DBMET03180 | |
| 0.012 | 0.061 | 0.026 | Lysophosphatidic acid 1 receptor antagonist | 0.024 0.01 DBMET03180 0.026 0.009 DBMET03181 | DBMET03181 | |
| 0.008 | 0.057 | 0.016 | Alpha 2a adrenoreceptor agonist | 0.016 0.013 DBMET03181 | DBMET03181 | |
| 0.033 | 0.082 | 0.088 | Argininosuccinate synthase inhibitor | 0.088 0.022 DBMET00316 0.081 0.025 DBMET03178 | DBMET00316 | |
| 0.019 | 0.068 | 0.042 | Somatostatin 1 antagonist | 0.042 0.025 DBMET00316 | DBMET00316 | |
| 0.004 | 0.055 | 0.014 | Glutamate (mGluR6) agonist | 0.014 0.007 DBMET00316 | DBMET00316 | |
| 0.024 | 0.075 | 0.035 | Membrane dipeptidase inhibitor | 0.035 0.034 DBMET03181 | DBMET03181 | |
| 0.028 | 0.079 | 0.073 | Dopamine transporter inhibitor | 0.073 0.019 DBMET00316 | DBMET00316 | |
| 0.121 | 0.172 | 0.487 | Aldehyde oxidase inhibitor | 0.149 0.14 DBMET00316 0.188 0.111 DBMET03178 0.487 0.035 DBMET03180 0.375 0.051 DBMET03181 | DBMET03180 | |
| 0.069 | 0.12 | 0.234 | Ferrochelatase inhibitor | 0.156 0.035 DBMET00316 0.165 0.032 DBMET03178 0.193 0.024 DBMET03180 0.234 0.016 DBMET03181 | DBMET03181 | |
| 0.027 | 0.079 | 0.053 | Thymidine kinase inhibitor | 0.041 0.029 DBMET03178 0.053 0.017 DBMET03180 | DBMET03180 | |
| 0.014 | 0.068 | 0.026 | Nicotinic acid receptor 2 antagonist | 0.026 0.019 DBMET03178 0.024 0.023 DBMET03180 | DBMET03178 | |
| 0.022 | 0.076 | 0.034 | Retinoid X alpha receptor antagonist | 0.034 0.024 DBMET03178 0.033 0.026 DBMET03180 | DBMET03178 | |
| 0.018 | 0.072 | 0.071 | Kainate receptor antagonist | 0.071 0.012 DBMET00316 0.044 0.026 DBMET03179 | DBMET00316 | |
| 0.082 | 0.136 | 0.206 | Aldehyde dehydrogenase inhibitor | 0.113 0.079 DBMET00316 0.2 0.028 DBMET03178 0.206 0.026 DBMET03180 0.141 0.053 DBMET03181 | DBMET03180 | |
| 0.017 | 0.071 | 0.029 | Estrogen-related receptor alpha antagonist | 0.029 0.028 DBMET03178 | DBMET03178 | |
| 0.013 | 0.067 | 0.256 | Histone deacetylase class IIa inhibitor | 0.256 0.004 DBMET03179 | DBMET03179 | |
| 0.005 | 0.059 | 0.03 | Kainate receptor 1 antagonist | 0.03 0.01 DBMET00316 | DBMET00316 | |
| 0.014 | 0.069 | 0.052 | Kainate receptor 2 antagonist | 0.052 0.015 DBMET00316 | DBMET00316 | |
| 0.025 | 0.08 | 0.08 | Stearoyl-CoA desaturase inhibitor | 0.08 0.011 DBMET03178 0.043 0.031 DBMET03180 0.048 0.025 DBMET03181 | DBMET03178 | |
| 0.039 | 0.094 | 0.069 | Glucosylceramidase inhibitor | 0.069 0.023 DBMET03180 0.064 0.027 DBMET03181 | DBMET03180 | |
| 0.028 | 0.084 | 0.048 | Vanilloid 3 antagonist | 0.045 0.013 DBMET03178 0.048 0.01 DBMET03180 0.039 0.024 DBMET03181 | DBMET03180 | |
| 0.034 | 0.09 | 0.074 | NMDA receptor glycine site agonist | 0.074 0.033 DBMET00316 0.062 0.043 DBMET03180 | DBMET00316 | |
| 0.111 | 0.168 | 0.733 | Interleukin antagonist | 0.224 0.072 DBMET00316 0.259 0.058 DBMET03180 0.733 0.004 DBMET03181 | DBMET03181 | |
| 0.048 | 0.105 | 0.058 | Trypsin inhibitor | 0.058 0.053 DBMET00316 | DBMET00316 | |
| 0.011 | 0.068 | 0.018 | Antibiotic Anthracycline-like | 0.018 0.016 DBMET03180 | DBMET03180 | |
| 0.013 | 0.071 | 0.019 | Retinoid X beta receptor antagonist | 0.019 0.018 DBMET03178 | DBMET03178 | |
| 0.005 | 0.063 | 0.084 | Peroxisome proliferator-activated receptor alpha antagonist | 0.084 0.005 DBMET03180 0.031 0.011 DBMET03181 | DBMET03180 | |
| 0.02 | 0.079 | 0.037 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.036 0.021 DBMET03178 0.037 0.02 DBMET03180 | DBMET03180 | |
| 0.024 | 0.084 | 0.081 | Matrix metalloproteinase 1 inhibitor | 0.081 0.021 DBMET03179 | DBMET03179 | |
| 0.066 | 0.126 | 0.089 | Polo-like kinase-1 inhibitor | 0.089 0.063 DBMET00316 | DBMET00316 | |
| 0.004 | 0.063 | 0.135 | Prostaglandin EP4 agonist | 0.034 0.007 DBMET03178 0.135 0.003 DBMET03180 0.12 0.003 DBMET03181 | DBMET03180 | |
| 0.027 | 0.087 | 0.06 | Dihydroorotate dehydrogenase inhibitor | 0.06 0.028 DBMET03178 0.056 0.031 DBMET03180 | DBMET03178 | |
| 0.024 | 0.084 | 0.038 | Retinoid X receptor antagonist | 0.038 0.027 DBMET03178 0.037 0.029 DBMET03180 | DBMET03178 | |
| 0.005 | 0.066 | 0.015 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.015 0.007 DBMET03179 | DBMET03179 | |
| 0.036 | 0.097 | 0.104 | Protein kinase C iota inhibitor | 0.104 0.018 DBMET00316 | DBMET00316 | |
| 0.052 | 0.114 | 0.097 | Glycine receptor agonist | 0.097 0.023 DBMET00316 0.077 0.043 DBMET03178 0.081 0.037 DBMET03180 0.067 0.06 DBMET03181 | DBMET00316 | |
| 0.139 | 0.202 | 0.16 | MAP kinase kinase 5 inhibitor | 0.16 0.116 DBMET00316 | DBMET00316 | |
| 0.042 | 0.105 | 0.195 | Porphobilinogen synthase inhibitor | 0.065 0.061 DBMET00316 0.195 0.013 DBMET03178 0.082 0.046 DBMET03180 | DBMET03178 | |
| 0.046 | 0.11 | 0.076 | Interferon inducer | 0.075 0.028 DBMET03180 0.076 0.027 DBMET03181 | DBMET03181 | |
| 0.053 | 0.117 | 0.081 | Histamine N-methyltransferase inhibitor | 0.081 0.066 DBMET00316 | DBMET00316 | |
| 0.015 | 0.08 | 0.088 | Fumarate hydratase inhibitor | 0.038 0.02 DBMET00316 0.052 0.013 DBMET03178 0.088 0.006 DBMET03180 0.045 0.015 DBMET03181 | DBMET03180 | |
| 0.058 | 0.122 | 0.137 | Urease inhibitor | 0.098 0.069 DBMET00316 0.121 0.044 DBMET03178 0.137 0.031 DBMET03179 0.117 0.048 DBMET03181 | DBMET03179 | |
| 0.022 | 0.088 | 0.081 | Adenosine deaminase inhibitor | 0.055 0.025 DBMET00316 0.081 0.009 DBMET03180 0.064 0.018 DBMET03181 | DBMET03180 | |
| 0.042 | 0.108 | 0.108 | Nav1.7 sodium channel blocker | 0.062 0.054 DBMET00316 0.108 0.02 DBMET03181 | DBMET03181 | |
| 0.174 | 0.24 | 0.298 | Interleukin 2 agonist | 0.298 0.075 DBMET00316 0.226 0.148 DBMET03180 0.251 0.117 DBMET03181 | DBMET00316 | |
| 0.015 | 0.082 | 0.037 | Phosphoglycerate kinase inhibitor | 0.037 0.022 DBMET03180 0.034 0.025 DBMET03181 | DBMET03180 | |
| 0.09 | 0.157 | 0.173 | Sphingosine 1-phosphate receptor 4 antagonist | 0.157 0.028 DBMET00316 0.173 0.018 DBMET03178 0.155 0.029 DBMET03180 | DBMET03178 | |
| 0.04 | 0.107 | 0.123 | Histidine decarboxylase inhibitor | 0.123 0.025 DBMET00316 0.092 0.035 DBMET03178 0.088 0.037 DBMET03180 | DBMET00316 | |
| 0.032 | 0.1 | 0.075 | Alpha-mannosidase inhibitor | 0.065 0.021 DBMET03180 0.075 0.014 DBMET03181 | DBMET03181 | |
| 0.021 | 0.09 | 0.057 | Glutamate (mGluR group I) agonist | 0.057 0.025 DBMET00316 | DBMET00316 | |
| 0.024 | 0.093 | 0.059 | Metalloproteinase-3 inhibitor | 0.059 0.024 DBMET03179 | DBMET03179 | |
| 0.086 | 0.156 | 0.359 | Peroxidase inhibitor | 0.179 0.066 DBMET00316 0.26 0.045 DBMET03179 0.226 0.053 DBMET03180 0.359 0.027 DBMET03181 | DBMET03181 | |
| 0.035 | 0.106 | 0.056 | CD45 antagonist | 0.056 0.025 DBMET03180 | DBMET03180 | |
| 0.069 | 0.14 | 0.242 | Cholesterol synthesis inhibitor | 0.129 0.058 DBMET03178 0.242 0.019 DBMET03180 0.211 0.024 DBMET03181 | DBMET03180 | |
| 0.031 | 0.102 | 0.045 | Histamine H4 receptor antagonist | 0.045 0.042 DBMET00316 | DBMET00316 | |
| 0.004 | 0.076 | 0.034 | G-protein-coupled receptor 120 agonist | 0.02 0.009 DBMET03178 0.034 0.005 DBMET03180 | DBMET03180 | |
| 0.117 | 0.189 | 0.161 | Focal adhesion kinase 2 inhibitor | 0.161 0.114 DBMET00316 | DBMET00316 | |
| 0.039 | 0.112 | 0.116 | Glutamate receptor agonist | 0.116 0.028 DBMET00316 0.07 0.063 DBMET03178 | DBMET00316 | |
| 0.097 | 0.17 | 0.122 | Papain-like protease (SARS coronavirus) inhibitor | 0.122 0.077 DBMET03180 | DBMET03180 | |
| 0.031 | 0.104 | 0.119 | Aconitate hydratase inhibitor | 0.055 0.032 DBMET00316 0.085 0.012 DBMET03178 0.119 0.006 DBMET03180 0.102 0.008 DBMET03181 | DBMET03180 | |
| 0.032 | 0.107 | 0.399 | 5 Hydroxytryptamine agonist | 0.399 0.005 DBMET00316 | DBMET00316 | |
| 0.005 | 0.08 | 0.011 | Calcium-dependent phospholipase A2 inhibitor | 0.011 0.01 DBMET03178 | DBMET03178 | |
| 0.038 | 0.114 | 0.11 | Histone deacetylase inhibitor | 0.058 0.057 DBMET03178 0.11 0.015 DBMET03179 | DBMET03179 | |
| 0.018 | 0.095 | 0.056 | Alpha 1d adrenoreceptor agonist | 0.056 0.013 DBMET03181 | DBMET03181 | |
| 0.05 | 0.128 | 0.091 | Interferon agonist | 0.09 0.039 DBMET03180 0.091 0.038 DBMET03181 | DBMET03181 | |
| 0.167 | 0.246 | 0.225 | MAP kinase kinase 3 inhibitor | 0.225 0.064 DBMET00316 0.19 0.153 DBMET03178 | DBMET00316 | |
| 0.132 | 0.212 | 0.492 | Hypoglycemic | 0.169 0.148 DBMET00316 0.492 0.016 DBMET03180 0.244 0.081 DBMET03181 | DBMET03180 | |
| 0.168 | 0.249 | 0.496 | Histamine release inhibitor | 0.294 0.127 DBMET00316 0.257 0.15 DBMET03178 0.465 0.043 DBMET03180 0.496 0.03 DBMET03181 | DBMET03181 | |
| 0.046 | 0.128 | 0.094 | GABA aminotransferase inhibitor | 0.094 0.032 DBMET00316 0.075 0.054 DBMET03180 | DBMET00316 | |
| 0.103 | 0.186 | 0.177 | Interferon gamma antagonist | 0.142 0.09 DBMET00316 0.131 0.108 DBMET03178 0.177 0.052 DBMET03180 0.16 0.066 DBMET03181 | DBMET03180 | |
| 0.067 | 0.151 | 0.191 | AMP-activated protein kinase stimulant | 0.104 0.065 DBMET03178 0.191 0.012 DBMET03180 0.121 0.048 DBMET03181 | DBMET03180 | |
| 0.065 | 0.149 | 0.097 | MAP kinase kinase 1 inhibitor | 0.097 0.061 DBMET03180 0.085 0.078 DBMET03181 | DBMET03180 | |
| 0.009 | 0.093 | 0.105 | Histone deacetylase 10 inhibitor | 0.105 0.005 DBMET03179 | DBMET03179 | |
| 0.05 | 0.136 | 0.072 | Keratolytic | 0.072 0.062 DBMET03180 | DBMET03180 | |
| 0.062 | 0.15 | 0.102 | Bile acid receptor antagonist | 0.091 0.071 DBMET00316 0.102 0.044 DBMET03178 0.097 0.056 DBMET03180 | DBMET03178 | |
| 0.033 | 0.121 | 0.114 | Prostaglandin-E synthase inhibitor | 0.114 0.021 DBMET03178 0.086 0.035 DBMET03180 | DBMET03178 | |
| 0.042 | 0.13 | 0.069 | Leukotriene C antagonist | 0.064 0.022 DBMET03178 0.069 0.015 DBMET03180 0.056 0.039 DBMET03181 | DBMET03180 | |
| 0.021 | 0.11 | 0.066 | Mannosidase inhibitor | 0.053 0.022 DBMET03180 0.066 0.014 DBMET03181 | DBMET03181 | |
| 0.009 | 0.099 | 0.027 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.027 0.019 DBMET03178 | DBMET03178 | |
| 0.056 | 0.147 | 0.163 | Expectorant | 0.099 0.07 DBMET00316 0.095 0.075 DBMET03178 0.131 0.044 DBMET03180 0.163 0.03 DBMET03181 | DBMET03181 | |
| 0.029 | 0.12 | 0.062 | Leukotriene B4 antagonist | 0.057 0.032 DBMET03180 0.062 0.025 DBMET03181 | DBMET03181 | |
| 0.114 | 0.206 | 0.15 | Phospholipase C inhibitor | 0.15 0.105 DBMET00316 0.146 0.115 DBMET03180 | DBMET00316 | |
| 0.021 | 0.115 | 0.041 | NMDA receptor subunit 3B antagonist | 0.041 0.034 DBMET00316 | DBMET00316 | |
| 0.103 | 0.197 | 0.169 | CF transmembrane conductance regulator agonist | 0.149 0.078 DBMET00316 0.154 0.069 DBMET03178 0.169 0.047 DBMET03180 0.133 0.11 DBMET03181 | DBMET03180 | |
| 0.023 | 0.118 | 0.046 | Glutamate (mGluR8) antagonist | 0.046 0.01 DBMET00316 | DBMET00316 | |
| 0.034 | 0.13 | 0.076 | Sphingosine 1-phosphate receptor 5 agonist | 0.076 0.014 DBMET03180 0.061 0.024 DBMET03181 | DBMET03180 | |
| 0.027 | 0.123 | 0.042 | Leukotriene C4 antagonist | 0.042 0.019 DBMET03178 0.042 0.02 DBMET03180 | DBMET03180 | |
| 0.014 | 0.112 | 0.045 | Histone deacetylase class I inhibitor | 0.045 0.022 DBMET03179 | DBMET03179 | |
| 0.065 | 0.163 | 0.078 | T cell inhibitor | 0.078 0.073 DBMET03178 | DBMET03178 | |
| 0.083 | 0.184 | 0.228 | Diuretic | 0.174 0.058 DBMET03178 0.228 0.035 DBMET03180 | DBMET03180 | |
| 0.025 | 0.125 | 0.053 | Diacylglycerol O-acyltransferase inhibitor | 0.053 0.033 DBMET03178 0.049 0.037 DBMET03180 | DBMET03178 | |
| 0.018 | 0.119 | 0.043 | GABA uptake inhibitor | 0.043 0.022 DBMET03180 | DBMET03180 | |
| 0.011 | 0.113 | 0.221 | 5 Hydroxytryptamine 2C agonist | 0.221 0.004 DBMET00316 | DBMET00316 | |
| 0.046 | 0.149 | 0.085 | Glutamate (mGluR6) antagonist | 0.085 0.019 DBMET00316 0.065 0.052 DBMET03180 0.062 0.059 DBMET03181 | DBMET00316 | |
| 0.027 | 0.13 | 0.082 | Carbamoyl phosphate synthetase inhibitor | 0.071 0.034 DBMET00316 0.055 0.048 DBMET03178 0.082 0.027 DBMET03180 0.071 0.034 DBMET03181 | DBMET03180 | |
| 0.051 | 0.155 | 0.163 | HIV-1 integrase (Overall Integration) inhibitor | 0.117 0.042 DBMET00316 0.163 0.021 DBMET03178 0.12 0.039 DBMET03180 0.14 0.029 DBMET03181 | DBMET03178 | |
| 0.003 | 0.107 | 0.016 | Thromboxane agonist | 0.016 0.004 DBMET03180 0.013 0.005 DBMET03181 | DBMET03180 | |
| 0.03 | 0.135 | 0.065 | Heparanase inhibitor | 0.065 0.016 DBMET03178 | DBMET03178 | |
| 0.01 | 0.116 | 0.044 | G protein-coupled receptor agonist | 0.044 0.021 DBMET03180 | DBMET03180 | |
| 0.009 | 0.114 | 0.243 | Histone deacetylase 5 inhibitor | 0.243 0.004 DBMET03179 | DBMET03179 | |
| 0.134 | 0.243 | 0.22 | RNA-directed DNA polymerase inhibitor | 0.184 0.125 DBMET00316 0.167 0.159 DBMET03178 0.22 0.074 DBMET03180 0.186 0.122 DBMET03181 | DBMET03180 | |
| 0.054 | 0.162 | 0.182 | UDP-glucose 4-epimerase inhibitor | 0.182 0.021 DBMET03178 0.174 0.022 DBMET03180 0.146 0.03 DBMET03181 | DBMET03178 | |
| 0.016 | 0.126 | 0.133 | Macrophage elastase inhibitor | 0.133 0.006 DBMET03179 | DBMET03179 | |
| 0.052 | 0.163 | 0.086 | GABA B receptor agonist | 0.071 0.066 DBMET00316 0.073 0.059 DBMET03178 0.082 0.038 DBMET03180 0.086 0.03 DBMET03181 | DBMET03181 | |
| 0.114 | 0.225 | 0.322 | Catenin beta inhibitor | 0.322 0.005 DBMET03180 | DBMET03180 | |
| 0.168 | 0.28 | 0.195 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.195 0.179 DBMET00316 | DBMET00316 | |
| 0.064 | 0.176 | 0.11 | Interleukin 12 antagonist | 0.099 0.055 DBMET00316 0.096 0.061 DBMET03178 0.11 0.04 DBMET03180 | DBMET03180 | |
| 0.084 | 0.197 | 0.206 | Arachidonic acid antagonist | 0.127 0.117 DBMET00316 0.206 0.027 DBMET03178 0.198 0.035 DBMET03180 0.173 0.062 DBMET03181 | DBMET03178 | |
| 0.071 | 0.184 | 0.127 | Acetylcholine release stimulant | 0.127 0.038 DBMET03178 | DBMET03178 | |
| 0.011 | 0.124 | 0.042 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.042 0.015 DBMET03178 0.03 0.025 DBMET03180 | DBMET03178 | |
| 0.006 | 0.12 | 0.06 | Prostaglandin EP2 agonist | 0.06 0.004 DBMET03180 0.059 0.005 DBMET03181 | DBMET03180 | |
| 0.019 | 0.135 | 0.059 | NMDA 2C receptor antagonist | 0.059 0.047 DBMET00316 | DBMET00316 | |
| 0.03 | 0.149 | 0.048 | Heme oxygenase inhibitor | 0.048 0.017 DBMET03178 0.047 0.017 DBMET03180 0.045 0.024 DBMET03181 | DBMET03178 | |
| 0.059 | 0.178 | 0.081 | Vanilloid agonist | 0.081 0.068 DBMET03180 | DBMET03180 | |
| 0.016 | 0.137 | 0.054 | Oleamide hydrolase inhibitor | 0.054 0.024 DBMET03178 | DBMET03178 | |
| 0.025 | 0.148 | 0.301 | Peroxisome proliferator-activated receptor gamma agonist | 0.078 0.042 DBMET03178 0.301 0.005 DBMET03180 0.085 0.037 DBMET03181 | DBMET03180 | |
| 0.022 | 0.145 | 0.073 | NMDA 2 receptor antagonist | 0.073 0.049 DBMET00316 | DBMET00316 | |
| 0.024 | 0.148 | 0.133 | Phosphofructokinase-1 inhibitor | 0.068 0.049 DBMET00316 0.08 0.041 DBMET03178 0.133 0.022 DBMET03180 0.099 0.032 DBMET03181 | DBMET03180 | |
| 0.057 | 0.181 | 0.111 | Histone deacetylase class III inhibitor | 0.111 0.078 DBMET00316 | DBMET00316 | |
| 0.025 | 0.151 | 0.093 | Aldosterone antagonist | 0.061 0.019 DBMET03178 0.093 0.009 DBMET03180 | DBMET03180 | |
| 0.051 | 0.179 | 0.165 | Triose-phosphate isomerase inhibitor | 0.119 0.033 DBMET03178 0.114 0.036 DBMET03179 0.164 0.016 DBMET03180 0.165 0.016 DBMET03181 | DBMET03181 | |
| 0.012 | 0.141 | 0.042 | Urokinase inhibitor | 0.042 0.037 DBMET00316 | DBMET00316 | |
| 0.008 | 0.137 | 0.122 | Prostaglandin agonist | 0.037 0.016 DBMET03178 0.122 0.004 DBMET03180 0.098 0.005 DBMET03181 | DBMET03180 | |
| 0.049 | 0.178 | 0.076 | MDM2 inhibitor | 0.066 0.053 DBMET03178 0.076 0.025 DBMET03180 | DBMET03180 | |
| 0.01 | 0.139 | 0.042 | Sodium/glucose cotransporter inhibitor | 0.042 0.006 DBMET03180 0.028 0.013 DBMET03181 | DBMET03180 | |
| 0.043 | 0.172 | 0.065 | Transcription factor RelA inhibitor | 0.065 0.041 DBMET03178 | DBMET03178 | |
| 0.013 | 0.144 | 0.052 | Glutamate (mGluR group II) antagonist | 0.052 0.014 DBMET00316 0.035 0.031 DBMET03180 | DBMET00316 | |
| 0.027 | 0.159 | 0.21 | Lipase inhibitor | 0.21 0.005 DBMET03181 | DBMET03181 | |
| 0.004 | 0.136 | 0.091 | Prostaglandin E2 agonist | 0.023 0.017 DBMET03178 0.091 0.004 DBMET03180 0.071 0.005 DBMET03181 | DBMET03180 | |
| 0.007 | 0.139 | 0.04 | Uridine phosphorylase inhibitor | 0.04 0.012 DBMET03180 0.028 0.019 DBMET03181 | DBMET03180 | |
| 0.119 | 0.253 | 0.168 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.158 0.131 DBMET03178 0.157 0.133 DBMET03180 0.168 0.112 DBMET03181 | DBMET03181 | |
| 0.147 | 0.283 | 0.273 | Caspase 3 stimulant | 0.273 0.095 DBMET03178 0.23 0.131 DBMET03180 | DBMET03178 | |
| 0.076 | 0.214 | 0.209 | Cell wall synthesis inhibitor | 0.127 0.09 DBMET00316 0.134 0.082 DBMET03180 0.209 0.027 DBMET03181 | DBMET03181 | |
| 0.08 | 0.219 | 0.129 | LIM domain kinase 1 inhibitor | 0.129 0.122 DBMET00316 | DBMET00316 | |
| 0.024 | 0.167 | 0.081 | Collagenase 3 inhibitor | 0.081 0.024 DBMET03179 | DBMET03179 | |
| 0.008 | 0.151 | 0.031 | Glutamate (mGluR2) antagonist | 0.031 0.018 DBMET00316 | DBMET00316 | |
| 0.024 | 0.167 | 0.069 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.069 0.027 DBMET03180 0.067 0.028 DBMET03181 | DBMET03180 | |
| 0.088 | 0.233 | 0.205 | Interleukin 6 antagonist | 0.168 0.066 DBMET00316 0.158 0.078 DBMET03179 0.205 0.038 DBMET03180 0.151 0.087 DBMET03181 | DBMET03180 | |
| 0.008 | 0.154 | 0.021 | Isoleucine-tRNA ligase inhibitor | 0.021 0.02 DBMET00316 | DBMET00316 | |
| 0.028 | 0.175 | 0.071 | Na+ K+ transporting ATPase inhibitor | 0.071 0.059 DBMET03180 0.067 0.063 DBMET03181 | DBMET03180 | |
| 0.106 | 0.253 | 0.143 | Death-associated protein kinase 2 inhibitor | 0.143 0.123 DBMET03179 | DBMET03179 | |
| 0.025 | 0.174 | 0.064 | Amidase inhibitor | 0.064 0.059 DBMET03178 | DBMET03178 | |
| 0.008 | 0.157 | 0.29 | Histone deacetylase class II inhibitor | 0.29 0.004 DBMET03179 | DBMET03179 | |
| 0.058 | 0.207 | 0.12 | Microtubule formation inhibitor | 0.102 0.087 DBMET03178 0.115 0.066 DBMET03180 0.12 0.06 DBMET03181 | DBMET03181 | |
| 0.078 | 0.229 | 0.131 | Sphingosine 1-phosphate receptor 2 agonist | 0.102 0.095 DBMET00316 0.131 0.04 DBMET03180 | DBMET03180 | |
| 0.066 | 0.218 | 0.23 | Angiogenesis stimulant | 0.23 0.079 DBMET00316 | DBMET00316 | |
| 0.046 | 0.2 | 0.08 | Estrogen receptor alpha antagonist | 0.08 0.049 DBMET03178 | DBMET03178 | |
| 0.007 | 0.162 | 0.041 | Sodium/glucose cotransporter 2 inhibitor | 0.041 0.008 DBMET03180 0.027 0.016 DBMET03181 | DBMET03180 | |
| 0.021 | 0.176 | 0.1 | Biliverdin reductase inhibitor | 0.1 0.018 DBMET03180 0.081 0.026 DBMET03181 | DBMET03180 | |
| 0.033 | 0.191 | 0.085 | Histone deacetylase stimulant | 0.085 0.039 DBMET03180 | DBMET03180 | |
| 0.033 | 0.191 | 0.085 | Histone deacetylase SIRT1 stimulant | 0.085 0.039 DBMET03180 | DBMET03180 | |
| 0.067 | 0.231 | 0.16 | Protein kinase stimulant | 0.146 0.071 DBMET03180 0.16 0.062 DBMET03181 | DBMET03181 | |
| 0.023 | 0.188 | 0.064 | Glucose-6-phosphate isomerase inhibitor | 0.049 0.031 DBMET03178 0.045 0.038 DBMET03179 0.064 0.016 DBMET03180 0.059 0.019 DBMET03181 | DBMET03180 | |
| 0.006 | 0.173 | 0.273 | Histone deacetylase 6 inhibitor | 0.273 0.004 DBMET03179 | DBMET03179 | |
| 0.006 | 0.175 | 0.273 | Histone deacetylase class IIb inhibitor | 0.273 0.004 DBMET03179 | DBMET03179 | |
| 0.017 | 0.188 | 0.108 | Alcohol oxidase inhibitor | 0.108 0.016 DBMET03180 0.089 0.021 DBMET03181 | DBMET03180 | |
| 0.092 | 0.265 | 0.219 | Succinate dehydrogenase inhibitor | 0.141 0.131 DBMET00316 0.219 0.036 DBMET03178 0.196 0.052 DBMET03180 0.181 0.067 DBMET03181 | DBMET03178 | |
| 0.089 | 0.263 | 0.241 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.241 0.065 DBMET00316 | DBMET00316 | |
| 0.024 | 0.198 | 0.065 | Acetyl-CoA transferase 2 inhibitor | 0.065 0.023 DBMET03181 | DBMET03181 | |
| 0.058 | 0.234 | 0.304 | Electron transport complex I inhibitor | 0.27 0.005 DBMET03178 0.304 0.005 DBMET03180 0.17 0.013 DBMET03181 | DBMET03180 | |
| 0.021 | 0.2 | 0.075 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.075 0.019 DBMET03180 0.061 0.029 DBMET03181 | DBMET03180 | |
| 0.005 | 0.186 | 0.169 | Histone deacetylase 3 inhibitor | 0.169 0.005 DBMET03179 | DBMET03179 | |
| 0.138 | 0.32 | 0.296 | Antibacterial | 0.281 0.15 DBMET03180 0.296 0.139 DBMET03181 | DBMET03181 | |
| 0.039 | 0.222 | 0.102 | Gastric antisecretory | 0.102 0.063 DBMET03180 | DBMET03180 | |
| 0.02 | 0.207 | 0.099 | Leukotriene antagonist | 0.099 0.022 DBMET03180 0.072 0.038 DBMET03181 | DBMET03180 | |
| 0.026 | 0.223 | 0.185 | Monophenol monooxygenase inhibitor | 0.185 0.037 DBMET03178 0.114 0.065 DBMET03180 | DBMET03178 | |
| 0.005 | 0.206 | 0.032 | Aggrecanase 2 inhibitor | 0.032 0.009 DBMET03179 | DBMET03179 | |
| 0.117 | 0.32 | 0.309 | Peptidyltransferase inhibitor | 0.164 0.159 DBMET03180 0.309 0.022 DBMET03181 | DBMET03181 | |
| 0.063 | 0.27 | 0.149 | Protein kinase (CK1) gamma 3 inhibitor | 0.149 0.091 DBMET00316 | DBMET00316 | |
| 0.039 | 0.246 | 0.102 | Cystathionine beta-synthase inhibitor | 0.102 0.074 DBMET00316 0.096 0.082 DBMET03178 0.095 0.083 DBMET03180 | DBMET00316 | |
| 0.098 | 0.307 | 0.196 | 12-Lipoxygenase inhibitor | 0.196 0.156 DBMET03178 | DBMET03178 | |
| 0.008 | 0.22 | 0.031 | 1,3-Beta-glucan synthase inhibitor | 0.031 0.014 DBMET03181 | DBMET03181 | |
| 0.015 | 0.228 | 0.049 | Mineralocorticoid receptor antagonist | 0.049 0.031 DBMET03180 | DBMET03180 | |
| 0.028 | 0.241 | 0.141 | Protein-tyrosine phosphatase 1B inhibitor | 0.141 0.049 DBMET03180 | DBMET03180 | |
| 0.008 | 0.224 | 0.047 | Guanylate cyclase inhibitor | 0.047 0.024 DBMET03178 0.039 0.035 DBMET03180 | DBMET03178 | |
| 0.045 | 0.266 | 0.131 | Bone formation stimulant | 0.131 0.076 DBMET03180 | DBMET03180 | |
| 0.022 | 0.247 | 0.108 | Glucose-6-phosphate translocase inhibitor | 0.108 0.005 DBMET03178 | DBMET03178 | |
| 0.028 | 0.254 | 0.123 | Macrophage migration inhibitory factor inhibitor | 0.123 0.024 DBMET03178 | DBMET03178 | |
| 0.016 | 0.245 | 0.101 | ADAM10 endopeptidase inhibitor | 0.101 0.004 DBMET03179 | DBMET03179 | |
| 0.014 | 0.247 | 0.1 | Plasminogen activator inhibitor antagonist | 0.1 0.01 DBMET03180 | DBMET03180 | |
| 0.096 | 0.333 | 0.223 | Hypoxia-inducible factor 1 alpha inhibitor | 0.223 0.126 DBMET03181 | DBMET03181 | |
| 0.005 | 0.242 | 0.035 | Urate transporter 1 inhibitor | 0.035 0.032 DBMET03180 | DBMET03180 | |
| 0.005 | 0.244 | 0.04 | Farnesoid X receptor agonist | 0.04 0.023 DBMET03180 | DBMET03180 | |
| 0.019 | 0.258 | 0.101 | Neuraminidase (influenza) inhibitor | 0.07 0.035 DBMET03180 0.101 0.016 DBMET03181 | DBMET03181 | |
| 0.071 | 0.312 | 0.192 | Non-steroidal antiinflammatory agent | 0.186 0.083 DBMET00316 0.192 0.078 DBMET03178 0.184 0.084 DBMET03180 0.16 0.104 DBMET03181 | DBMET03178 | |
| 0.014 | 0.263 | 0.071 | Acetyl-CoA transferase inhibitor | 0.071 0.024 DBMET03178 | DBMET03178 | |
| 0.037 | 0.287 | 0.083 | Factor XII inhibitor | 0.083 0.06 DBMET00316 | DBMET00316 | |
| 0.008 | 0.259 | 0.029 | ATP citrate lysase inhibitor | 0.029 0.026 DBMET03180 | DBMET03180 | |
| 0.047 | 0.3 | 0.133 | Antibacterial (Helicobacter pylori) | 0.133 0.064 DBMET03178 | DBMET03178 | |
| 0.012 | 0.268 | 0.145 | Neuraminidase inhibitor | 0.065 0.038 DBMET03180 0.145 0.006 DBMET03181 | DBMET03181 | |
| 0.088 | 0.346 | 0.274 | Growth factor agonist | 0.274 0.022 DBMET03178 0.161 0.118 DBMET03181 | DBMET03178 | |
| 0.007 | 0.265 | 0.296 | Histone deacetylase 2 inhibitor | 0.296 0.005 DBMET03179 | DBMET03179 | |
| 0.008 | 0.267 | 0.05 | Phosphodiesterase II inhibitor | 0.05 0.049 DBMET03181 | DBMET03181 | |
| 0.052 | 0.313 | 0.147 | Interleukin 4 antagonist | 0.107 0.105 DBMET03180 0.147 0.053 DBMET03181 | DBMET03181 | |
| 0.009 | 0.27 | 0.119 | Prostaglandin E2 antagonist | 0.119 0.012 DBMET03180 | DBMET03180 | |
| 0.069 | 0.334 | 0.176 | Tumour necrosis factor antagonist | 0.176 0.071 DBMET03179 | DBMET03179 | |
| 0.046 | 0.312 | 0.104 | Phosphodiesterase 6D inhibitor | 0.098 0.056 DBMET03180 0.104 0.045 DBMET03181 | DBMET03181 | |
| 0.005 | 0.273 | 0.316 | Histone deacetylase 1 inhibitor | 0.316 0.005 DBMET03179 | DBMET03179 | |
| 0.009 | 0.283 | 0.118 | Prostaglandin antagonist | 0.118 0.014 DBMET03180 | DBMET03180 | |
| 0.013 | 0.287 | 0.053 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.053 0.048 DBMET03180 | DBMET03180 | |
| 0.004 | 0.279 | 0.025 | Kynurenine 3 monooxygenase inhibitor | 0.025 0.02 DBMET03181 | DBMET03181 | |
| 0.06 | 0.337 | 0.24 | Free radical scavenger | 0.169 0.125 DBMET03178 0.24 0.073 DBMET03181 | DBMET03181 | |
| 0.056 | 0.344 | 0.145 | P-glycoprotein inhibitor | 0.145 0.124 DBMET03180 | DBMET03180 | |
| 0.021 | 0.309 | 0.091 | Factor IXa inhibitor | 0.091 0.012 DBMET03181 | DBMET03181 | |
| 0.039 | 0.333 | 0.87 | Interleukin 1b antagonist | 0.165 0.031 DBMET03178 0.124 0.059 DBMET03179 0.87 0.002 DBMET03181 | DBMET03181 | |
| 0.064 | 0.364 | 0.281 | Antioxidant | 0.17 0.142 DBMET03180 0.281 0.069 DBMET03181 | DBMET03181 | |
| 0.089 | 0.392 | 0.211 | Immunomodulator | 0.211 0.151 DBMET03181 | DBMET03181 | |
| 0.019 | 0.327 | 0.095 | Prostaglandin F2 alpha antagonist | 0.094 0.014 DBMET03180 0.095 0.014 DBMET03181 | DBMET03181 | |
| 0.045 | 0.363 | 0.155 | Mannose-6-phosphate isomerase inhibitor | 0.155 0.06 DBMET03180 0.136 0.079 DBMET03181 | DBMET03180 | |
| 0.004 | 0.331 | 0.042 | HMG CoA reductase inhibitor | 0.042 0.012 DBMET03180 0.035 0.022 DBMET03181 | DBMET03180 | |
| 0.028 | 0.358 | 0.123 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.123 0.099 DBMET00316 | DBMET00316 | |
| 0.049 | 0.379 | 0.167 | Platelet adhesion inhibitor | 0.167 0.09 DBMET03178 | DBMET03178 | |
| 0.033 | 0.369 | 0.222 | Amylase inhibitor | 0.128 0.076 DBMET03180 0.222 0.037 DBMET03181 | DBMET03181 | |
| 0.07 | 0.41 | 0.426 | Lipocortins synthesis antagonist | 0.426 0.007 DBMET03178 | DBMET03178 | |
| 0.028 | 0.375 | 0.157 | Protein-tyrosine phosphatase inhibitor | 0.157 0.072 DBMET03180 | DBMET03180 | |
| 0.067 | 0.43 | 0.155 | Histone acetyltransferase inhibitor | 0.155 0.132 DBMET03180 | DBMET03180 | |
| 0.005 | 0.371 | 0.047 | Prostaglandin D2 agonist | 0.047 0.009 DBMET03181 | DBMET03181 | |
| 0.029 | 0.398 | 0.083 | Thioredoxin inhibitor | 0.083 0.075 DBMET03178 | DBMET03178 | |
| 0.028 | 0.397 | 0.195 | Aryl hydrocarbon receptor agonist | 0.195 0.105 DBMET03178 | DBMET03178 | |
| 0.04 | 0.412 | 0.095 | Toll-Like receptor 3 antagonist | 0.095 0.058 DBMET03181 | DBMET03181 | |
| 0.1 | 0.473 | 0.302 | Apoptosis agonist | 0.302 0.17 DBMET03178 | DBMET03178 | |
| 0.043 | 0.421 | 0.219 | Nitric oxide antagonist | 0.148 0.097 DBMET03178 0.166 0.083 DBMET03180 0.219 0.061 DBMET03181 | DBMET03181 | |
| 0.038 | 0.417 | 0.181 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.181 0.113 DBMET03178 | DBMET03178 | |
| 0.048 | 0.453 | 0.31 | Lipoxygenase inhibitor | 0.182 0.161 DBMET03178 0.31 0.067 DBMET03179 | DBMET03179 | |
| 0.043 | 0.45 | 0.796 | Tumour necrosis factor alpha release inhibitor | 0.474 0.017 DBMET03179 0.796 0.004 DBMET03181 | DBMET03181 | |
| 0.005 | 0.413 | 0.294 | Prostaglandin EP2 antagonist | 0.294 0.004 DBMET03180 0.117 0.015 DBMET03181 | DBMET03180 | |
| 0.011 | 0.425 | 0.063 | HIV-1 reverse transcriptase inhibitor | 0.063 0.055 DBMET03178 | DBMET03178 | |
| 0.003 | 0.421 | 0.058 | Prostaglandin EP3 antagonist | 0.058 0.008 DBMET03180 | DBMET03180 | |
| 0.047 | 0.471 | 0.206 | Hepatoprotectant | 0.143 0.118 DBMET03180 0.206 0.062 DBMET03181 | DBMET03181 | |
| 0.041 | 0.471 | 0.165 | Hexokinase inhibitor | 0.165 0.062 DBMET03178 0.152 0.077 DBMET03180 | DBMET03178 | |
| 0.011 | 0.464 | 0.101 | Leukotriene synthesis inhibitor | 0.101 0.025 DBMET03178 0.077 0.039 DBMET03180 | DBMET03178 | |
| 0.031 | 0.504 | 0.856 | Interleukin 1 antagonist | 0.138 0.067 DBMET03178 0.856 0.003 DBMET03181 | DBMET03181 | |
| 0.01 | 0.484 | 0.122 | 5-Lipoxygenase inhibitor | 0.122 0.049 DBMET03179 | DBMET03179 | |
| 0.026 | 0.555 | 0.103 | Interleukin 5 antagonist | 0.103 0.038 DBMET03181 | DBMET03181 | |
| 0 | 0.531 | 0.008 | Mannitol 2-dehydrogenase inhibitor | 0.008 0.006 DBMET03180 0.008 0.006 DBMET03181 | DBMET03181 | |
| 0.012 | 0.544 | 0.16 | Topoisomerase II inhibitor | 0.16 0.045 DBMET03181 | DBMET03181 | |
| 0.02 | 0.56 | 0.091 | Hedgehog signaling inhibitor | 0.091 0.084 DBMET03178 | DBMET03178 | |
| 0.015 | 0.564 | 0.088 | ATPase (Vacuolar H+) inhibitor | 0.081 0.077 DBMET03180 0.088 0.061 DBMET03181 | DBMET03181 | |
| 0.004 | 0.61 | 0.075 | Antineoplastic antibiotic | 0.075 0.061 DBMET03180 | DBMET03180 | |
| 0.005 | 0.721 | 0.072 | HIV-1 integrase inhibitor | 0.072 0.046 DBMET03178 | DBMET03178 | |
| 0.03 | 0.766 | 0.383 | Antiinflammatory | 0.383 0.149 DBMET03178 0.297 0.219 DBMET03180 0.348 0.174 DBMET03181 | DBMET03178 | |
| 0.018 | 0.766 | 0.149 | MAP3K9 inhibitor | 0.149 0.061 DBMET03181 | DBMET03181 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |